VEECO INSTRUMENTS INC, 10-K filed on 2/24/2015
Annual Report
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2014
Feb. 17, 2015
Jun. 27, 2014
Document and Entity Information
 
 
 
Entity Registrant Name
VEECO INSTRUMENTS INC 
 
 
Entity Central Index Key
0000103145 
 
 
Document Type
10-K 
 
 
Document Period End Date
Dec. 31, 2014 
 
 
Amendment Flag
false 
 
 
Current Fiscal Year End Date
--12-31 
 
 
Entity Well-known Seasoned Issuer
Yes 
 
 
Entity Voluntary Filers
No 
 
 
Entity Current Reporting Status
Yes 
 
 
Entity Filer Category
Large Accelerated Filer 
 
 
Entity Public Float
 
 
$ 1,454,417,866 
Entity Common Stock, Shares Outstanding
 
40,361,759 
 
Document Fiscal Year Focus
2014 
 
 
Document Fiscal Period Focus
FY 
 
 
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets:
 
 
Cash and cash equivalents
$ 270,811 
$ 210,799 
Short-term investments
120,572 
281,538 
Restricted cash
539 
2,738 
Accounts receivable, net
60,085 
23,823 
Inventories
61,471 
59,726 
Deferred cost of sales
5,076 
724 
Prepaid expenses and other current assets
23,132 
22,579 
Assets held for sale
6,000 
 
Deferred income taxes
7,976 
11,716 
Total current assets
555,662 
613,643 
Property, plant and equipment at cost, net
78,752 
89,139 
Goodwill
114,959 
91,348 
Deferred income taxes
1,180 
397 
Intangible assets, net
159,308 
114,716 
Other assets
19,594 
38,726 
Total assets
929,455 
947,969 
Current liabilities:
 
 
Accounts payable
18,111 
35,755 
Accrued expenses and other current liabilities
48,418 
51,084 
Customer deposits and deferred revenue
96,004 
34,754 
Income taxes payable
5,441 
6,149 
Deferred income taxes
120 
159 
Current portion of long-term debt
314 
290 
Total current liabilities
168,408 
128,191 
Deferred income taxes
16,397 
28,052 
Long-term debt
1,533 
1,847 
Other liabilities
4,185 
9,649 
Total liabilities
190,523 
167,739 
Stockholders' Equity:
 
 
Preferred stock, 500,000 shares authorized; no shares issued and outstanding
   
   
Common stock, $0.01 par value, 120,000,000 shares authorized; 40,360,069 and 39,666,195 shares issued and outstanding in 2014 and 2013, respectively
404 
397 
Additional paid-in capital
750,139 
721,352 
Retained earnings (accumulated deficit)
(13,080)
53,860 
Accumulated other comprehensive income
1,469 
4,621 
Total stockholders' equity
738,932 
780,230 
Total liabilities and stockholders' equity
$ 929,455 
$ 947,969 
Consolidated Balance Sheets (Parenthetical) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Consolidated Balance Sheets
 
 
Preferred stock, shares authorized
500,000 
500,000 
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in dollars per share)
$ 0.01 
$ 0.01 
Common stock, authorized shares
120,000,000 
120,000,000 
Common stock, shares issued
40,360,069 
39,666,195 
Common stock, shares outstanding
40,360,069 
39,666,195 
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Consolidated Statements of Operations
 
 
 
Net sales
$ 392,873 
$ 331,749 
$ 516,020 
Cost of sales
257,991 
228,607 
300,887 
Gross profit
134,882 
103,142 
215,133 
Operating expenses:
 
 
 
Selling, general and administrative
89,760 
85,486 
73,110 
Research and development
81,171 
81,424 
95,153 
Amortization
13,146 
5,527 
4,908 
Restructuring
4,394 
1,485 
3,813 
Asset impairment
58,170 
1,220 
1,335 
Changes in contingent consideration
(29,368)
829 
 
Other, net
(3,182)
(1,017)
(398)
Total operating expenses, net
214,091 
174,954 
177,921 
Operating income (loss)
(79,209)
(71,812)
37,212 
Interest income
1,570 
1,200 
2,476 
Interest expense
(715)
(598)
(1,502)
Income (loss) from continuing operations before income taxes
(78,354)
(71,210)
38,186 
Income tax provision (benefit)
(11,414)
(28,947)
11,657 
Income (loss) from continuing operations
(66,940)
(42,263)
26,529 
Discontinued operations:
 
 
 
Income from discontinued operations before income taxes
 
 
6,269 
Income tax provision
 
 
1,870 
Income from discontinued operations
 
 
4,399 
Net income (loss)
$ (66,940)
$ (42,263)
$ 30,928 
Basic income (loss) per common share:
 
 
 
Continuing operations (in dollars per share)
$ (1.70)
$ (1.09)
$ 0.69 
Discontinued operations (in dollars per share)
 
 
$ 0.11 
Net Income (loss) (in dollars per share)
$ (1.70)
$ (1.09)
$ 0.80 
Diluted income (loss) per common share:
 
 
 
Continuing operations (in dollars per share)
$ (1.70)
$ (1.09)
$ 0.68 
Discontinued operations (in dollars per share)
 
 
$ 0.11 
Net Income (loss) (in dollars per share)
$ (1.70)
$ (1.09)
$ 0.79 
Weighted average number of shares:
 
 
 
Basic (in shares)
39,350 
38,807 
38,477 
Diluted (in shares)
39,350 
38,807 
39,051 
Consolidated Statements of Comprehensive Income (Loss) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Consolidated Statements of Comprehensive Income (Loss)
 
 
 
Net income (loss)
$ (66,940)
$ (42,263)
$ 30,928 
Other comprehensive income (loss), net of tax
 
 
 
Unrealized gain (loss) on available-for-sale securities
51 
34 
(118)
Benefit (provision) for income taxes
 
11 
50 
Less: Reclassification adjustments included in net income (loss)
(65)
(61)
(24)
Net unrealized loss on available-for-sale securities
(14)
(16)
(92)
Minimum pension liability
(145)
125 
(216)
Benefit (provision) for income taxes
 
(86)
79 
Net minimum pension liability
(145)
39 
(137)
Foreign currency translation
149 
(1,322)
(1,071)
Benefit (provision) for income taxes
 
(53)
683 
Less: Reclassification adjustments included in net income (loss)
(3,142)
 
 
Net foreign currency translation
(2,993)
(1,375)
(388)
Other comprehensive income (loss), net of tax
(3,152)
(1,352)
(617)
Comprehensive income (loss)
$ (70,092)
$ (43,615)
$ 30,311 
Consolidated Statements of Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2011
$ 435 
$ (200,175)
$ 688,353 
$ 265,317 
$ 6,590 
$ 760,520 
Balance (in shares) at Dec. 31, 2011
38,768,000 
 
 
 
 
 
Increase (Decrease) in Stockholders' Equity
 
 
 
 
 
 
Net income (loss)
 
 
 
30,928 
 
30,928 
Other comprehensive loss, net of tax
 
 
 
 
(617)
(617)
Share-based compensation expense
 
 
14,268 
 
 
14,268 
Net issuance under employee stock plans
11 
 
5,792 
 
 
5,803 
Net issuance under employee stock plans (in shares)
560,000 
 
 
 
 
 
Change due to retirement of treasury stock
(53)
200,175 
 
(200,122)
 
 
Retirement of treasury stock (in shares)
 
5,278,828 
 
 
 
 
Prior period debt conversion adjustment
 
 
310 
 
 
310 
Balance at Dec. 31, 2012
393 
 
708,723 
96,123 
5,973 
811,212 
Balance (in shares) at Dec. 31, 2012
39,328,000 
 
 
 
 
 
Increase (Decrease) in Stockholders' Equity
 
 
 
 
 
 
Net income (loss)
 
 
 
(42,263)
 
(42,263)
Other comprehensive loss, net of tax
 
 
 
 
(1,352)
(1,352)
Share-based compensation expense
 
 
13,130 
 
 
13,130 
Net issuance under employee stock plans
 
(501)
 
 
(497)
Net issuance under employee stock plans (in shares)
338,000 
 
 
 
 
 
Balance at Dec. 31, 2013
397 
 
721,352 
53,860 
4,621 
780,230 
Balance (in shares) at Dec. 31, 2013
39,666,000 
 
 
 
 
 
Increase (Decrease) in Stockholders' Equity
 
 
 
 
 
 
Net income (loss)
 
 
 
(66,940)
 
(66,940)
Other comprehensive loss, net of tax
 
 
 
 
(3,152)
(3,152)
Share-based compensation expense
 
 
18,813 
 
 
18,813 
Net issuance under employee stock plans
 
9,974 
 
 
9,981 
Net issuance under employee stock plans (in shares)
694,000 
 
 
 
 
 
Balance at Dec. 31, 2014
$ 404 
 
$ 750,139 
$ (13,080)
$ 1,469 
$ 738,932 
Balance (in shares) at Dec. 31, 2014
40,360,000 
 
 
 
 
 
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash Flows from Operating Activities
 
 
 
Net income (loss)
$ (66,940)
$ (42,263)
$ 30,928 
Adjustments to reconcile net income (loss) to net cash from operating activities:
 
 
 
Depreciation and amortization
24,573 
18,425 
16,192 
Deferred income taxes
(11,330)
(12,264)
(340)
Share-based compensation expense
18,813 
13,130 
14,268 
Excess tax benefits from equity-based compensation
 
 
(2,119)
Provision (recovery) for bad debt
(1,814)
1,946 
198 
Impairment of long-lived assets
58,170 
1,220 
1,335 
Gain on sale of lab tools
(1,549)
(767)
 
Gain on disposal of segment
 
 
(4,112)
Gain on cumulative translation adjustment
(3,142)
 
 
Changes in contingent consideration
(29,368)
829 
 
Changes in operating assets and liabilities:
 
 
 
Accounts receivable
(25,390)
36,898 
31,017 
Inventories and deferred cost of sales
6,513 
2,753 
53,937 
Prepaid expenses and other current assets
(2,245)
842 
8,524 
Accounts payable and accrued expenses
(5,534)
7,542 
(12,106)
Customer deposits and deferred revenue
55,536 
(17,329)
(34,227)
Income taxes receivable and payable, net
20,279 
(12,734)
1,853 
Other, net
5,497 
2,499 
9,253 
Discontinued operations
 
 
(2,638)
Net cash provided by operating activities
42,069 
727 
111,963 
Cash Flows from Investing Activities
 
 
 
Acquisition of business, net of cash acquired
(144,069)
(71,488)
 
Capital expenditures
(15,588)
(9,174)
(24,994)
Proceeds from the liquidation of investments
318,276 
499,645 
244,929 
Payments for purchases of investments
(157,737)
(589,099)
(165,080)
Payments for purchase of cost method investment
(2,388)
(2,391)
(10,341)
Proceeds from sale of assets from discontinued segment
 
 
3,758 
Proceeds from sale of lab tools
9,259 
4,440 
 
Other
350 
11 
49 
Net cash provided by (used in) investing activities
8,103 
(168,056)
48,321 
Cash Flows from Financing Activities
 
 
 
Proceeds from stock option exercises
12,056 
2,199 
5,409 
Restricted stock tax withholdings
(2,075)
(2,696)
(1,725)
Excess tax benefits from equity-based compensation
 
 
2,119 
Contingent consideration payments
 
(5,000)
 
Repayments of long-term debt
(290)
(269)
(248)
Net cash provided by (used in) financing activities
9,691 
(5,766)
5,555 
Effect of exchange rate changes on cash and cash equivalents
149 
(663)
796 
Net increase (decrease) in cash and cash equivalents
60,012 
(173,758)
166,635 
Cash and cash equivalents as of beginning of period
210,799 
384,557 
217,922 
Cash and cash equivalents as of end of period
270,811 
210,799 
384,557 
Supplemental disclosure of cash flow information
 
 
 
Interest paid
159 
357 
209 
Income taxes paid
$ 3,320 
$ 8,001 
$ 11,566 
Significant Accounting Policies
Significant Accounting Policies

Note 1 — Significant Accounting Policies

 

(a) Description of Business

 

Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” or the “Company”) operates in a single segment: the design, development, manufacture, and support of thin film process equipment primarily sold to make electronic devices including light emitting diodes (“LED”s), power electronics, wireless devices, hard disk drives, and semiconductors.

 

(b) Basis of Presentation

 

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (GAAP). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2014 the interim quarters ended on March 30, June 29 and September 28, and during 2013 the interim quarters ended on March 31, June 30 and September 29. The Company reports these interim quarters as March 31, June 30 and September 30 in its interim consolidated financial statements.

 

(c) Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) the best estimate of selling price for the Company’s products and services; (ii) allowances for doubtful accounts and inventory obsolescence; (iii) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (iv) the fair value of the Company’s reporting units and related goodwill; (v) the fair value, less cost to sell, of assets held for sale; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; and (x) income tax uncertainties. Actual results could differ from those estimates.

 

(d) Principles of Consolidation

 

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

 

(e) Foreign Currencies

 

Assets and liabilities of the Company’s foreign subsidiaries that operate using local functional currencies are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other, net” in the Consolidated Statements of Operations.

 

(f) Revenue Recognition

 

The Company recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists with a customer; delivery of the specified products has occurred or services have been rendered; prices are contractually fixed or determinable; and collectability is reasonably assured. Revenue is recorded including shipping and handling costs and excluding applicable taxes related to sales. A significant portion of the Company’s revenue is derived from contractual arrangements with customers that have multiple elements, such as systems, upgrades, components, spare parts, maintenance, and service plans. For sales arrangements that contain multiple elements, the arrangement is split into separate units of accounting if the individually delivered elements have value to the customer on a standalone basis. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a multiple element arrangement, based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. When there are separate units of accounting, the Company allocates revenue to each element based on the following selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; or the best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. The Company uses BESP for the majority of the elements in its arrangements.

 

The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition including its contractual obligations, the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majority of the arrangements, a customer source inspection of the system is performed in the Company’s facility or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. As such, the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery and, therefore, revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below. For new products, new applications of existing products or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred and fully recognized upon the receipt of final customer acceptance, assuming all other revenue recognition criteria have been met.

 

The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; that is, it does not require significant changes to the features or capabilities of the equipment or involve building elaborate interfaces or connections subsequent to factory acceptance. The Company has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage the Company to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, the Company accrues the cost of the installation at the time of revenue recognition for the system.

 

In many cases the Company’s products are sold with a billing retention, typically 10% of the sales price (the “retention amount”), which is typically payable by the customer when field acceptance provisions are completed. The amount of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount billed that is not contingent upon acceptance provisions or ii) the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.

 

The Company’s contractual terms with customers in Japan generally specify that title and risk and rewards of ownership transfer upon customer acceptance. As a result, for customers in Japan, revenue is recognized upon the receipt of written customer acceptance. During the fourth quarter of fiscal 2013, the Company began using a distributor for almost all of its product and service sales to customers in Japan. Title passes to the distributor upon shipment, however, due to customary local business practices, the risk and rewards of ownership of the system transfers to the end-customers upon their acceptance. As such, the Company recognizes revenue upon receipt of written acceptance from the end customer.

 

The Company recognizes revenue related to maintenance and service contracts ratably over the applicable contract term. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at the time of delivery in accordance with the terms of the applicable sales arrangement.

 

Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred, even if the related revenue is deferred in accordance with the above policy.

 

(g) Warranty Costs

 

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a semiannual basis when the actual product performance and/or field expense differs from original estimates.

 

(h) Shipping and Handling Costs

 

Shipping and handling costs are expenses incurred to move, package and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

 

(i) Research and Development Costs

 

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

 

(j) Advertising Expense

 

The cost of advertising is expensed as incurred and totaled $0.6 million, $0.5 million, and $0.8 million during 2014, 2013 and 2012, respectively.

 

(k) Accounting for Share-Based Compensation

 

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award. The expense for awards expected to vest is recognized over the employee’s requisite service period (generally the vesting period of the award). Awards expected to vest are estimated based on a combination of historical experience and future expectations.

 

The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

 

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards. The Black-Scholes model includes assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 16, “Stock Plans,” for additional information.

 

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company issues performance share units and awards (“PSUs” and “PSAs”). Compensation cost for PSUs and PSAs is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of the probability of a performance condition being met is recognized in the period of the change in estimate. At the conclusion of the performance period, the applicable number of shares of RSAs, RSUs, or unrestricted shares granted may vary based on the level of achievement of the performance targets.

 

(l) Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to uncertain tax positions in income tax expense. See Note 18, “Income Taxes,” for additional information.

 

(m) Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material credit losses on its investments.

 

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.7 million and $2.4 million at December 31, 2014 and 2013, respectively.

 

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable, but before maturity. The fees associates with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were insignificant for the fiscal years ended December 31, 2014, 2013, and 2012.

 

(n) Fair Value of Financial Instruments

 

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, is estimated using a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of securities.

 

(o) Cash, Cash Equivalents, and Short-Term Investments

 

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value.

 

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which may not be the U.S. dollar. Approximately 81% and 71% of cash and cash equivalents were maintained outside the United States at December 31, 2014 and 2013, respectively.

 

Marketable securities are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income.” These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other, net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

 

(p) Inventories

 

Inventories are stated at the lower of cost or market, with cost determined on a first-in, first-out basis. The Company reviews and sets standard costs on a periodic basis at current manufacturing costs in order to approximate actual costs. The Company assesses the valuation of all inventories, including manufacturing raw materials, work-in-process, finished goods, and spare parts, each quarter. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general market conditions, possible alternative uses, and ultimate realization of excess inventory. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Business Combinations,” for additional information.

 

(q) Business Combinations

 

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When a project underlying reported IPR&D is completed, the corresponding amount of IPR&D is amortized over the asset’s estimated useful life. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred in “Selling, General, and Administrative” in the Consolidated Statements of Operations. See Note 5, “Business Combinations,” for additional information.

 

(r) Goodwill and Indefinite-Lived Intangibles

 

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net of the acquisition-date amounts of the identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values as of the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated R&D efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the fourth quarter of each fiscal year or more frequently if impairment indicators arise.

 

The Company first performs a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount, and, if so, the Company then applies the two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting units to their carrying amount. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired, and the Company is not required to perform further testing. If the carrying amount of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and, if the carrying amount of the reporting unit’s goodwill exceeds its implied fair value, then the Company records an impairment loss equal to the difference.

 

The Company determines the fair value of its reporting units based on income and/or market approaches. Determining the fair value of a reporting unit involves the use of significant estimates and assumptions. These estimates and assumptions include revenues and expenses, working capital requirements, residual growth rates, discount rates, and future economic and market conditions. The Company considers historical data, current internal estimates, and market growth trends when developing financial projections. Market participant assumption estimates consider the information being used internally for business planning purposes, however, actual future results may differ from those estimates. Changes in judgments on any of these factors could materially affect the estimated value of the reporting unit.

 

(s) Long-Lived Assets and Cost Method Investment

 

Definite-lived intangible assets consist of purchased technology, customer-related intangible assets, patents, trademarks, covenants not-to-compete, and software licenses, and are initially recorded at fair value. Definite-lived intangibles are amortized over their estimated useful lives for periods up to 17 years, in a method reflecting the pattern in which the economic benefits are consumed, or straight-lined if such pattern cannot be reliably determined.

 

Property, plant and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

 

Long-lived assets and cost method investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

 

(t) Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU No. 2014-09: Revenue from Contracts with Customers. The amendments in this ASU require that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard outlines a five-step model to be used to make the revenue recognition determination and requires new financial statement disclosures. The standard is effective for interim and annual periods beginning after December 15, 2016 and allows entities to choose among different transition alternatives. The Company is evaluating the impact of adopting the standard on its consolidated financial statements and related financial statement disclosures, and has not yet determined which method of adoption will be selected.

 

The Company has evaluated other pronouncements recently issued but not yet adopted and does not believe the adoption of these pronouncements will have a material impact on the consolidated financial statements.

Income (Loss) Per Common Share
Income (Loss) Per Common Share

Note 2 — Income (Loss) Per Common Share

 

Basic income (loss) per common share is calculated by dividing net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted income per common share is calculated by dividing net income available to common stockholders by using the weighted average number of common shares and common share equivalents outstanding during the period. The computations of basic and diluted income (loss) per common share are as follows:

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands, except per share amounts)

 

Net income (loss)

 

$

(66,940

)

$

(42,263

)

$

30,928

 

Net income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(1.70

)

$

(1.09

)

$

0.80

 

Diluted

 

$

(1.70

)

$

(1.09

)

$

0.79

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

39,350

 

38,807

 

38,477

 

Effect of potentially dilutive share-based awards

 

 

 

574

 

Diluted weighted average shares outstanding

 

39,350

 

38,807

 

39,051

 

 

For the year ended December 31, 2014 and 2013, 0.7 million and 0.6 million common equivalent shares, respectively, were excluded from the computation of diluted net loss per share as their effect would be anti-dilutive since the Company incurred a net loss. The dilutive effect of outstanding options and restricted stock units is reflected in diluted income per common share by application of the treasury stock method. For the years ended December 31, 2014, 2013, and 2012, respectively, approximately 1.6 million, 1.3 million and 1.3 million potentially dilutive securities underlying restricted stock awards, restricted stock units, and options to purchase common stock were excluded from the calculation since they would have had an antidilutive effect on diluted income per common share.

Fair Value Measurements
Fair Value Measurements

Note 3 — Fair Value Measurements

 

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. The Company is required to classify certain assets and liabilities based on the following fair value hierarchy:

 

·

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

 

·

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

 

·

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

 

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts.

 

The following table presents the Company’s assets and (liabilities) that were measured at fair value on a recurring basis at December 31, 2014 and 2013:

 

 

 

December 31, 2014

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(in thousands)

 

U.S. treasuries

 

  $

81,527 

 

  $

 

  $

 

  $

81,527 

 

Corporate debt

 

 

39,045 

 

 

39,045 

 

Assets held for sale

 

 

6,000 

 

 

6,000 

 

 

 

 

December 31, 2013

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(in thousands)

 

U.S. treasuries

 

  $

130,977

 

  $

 

  $

 

  $

130,977

 

Corporate debt

 

 

77,601

 

 

77,601

 

Government agency securities

 

 

61,013

 

 

61,013

 

Commercial paper

 

 

11,947

 

 

11,947

 

Derivative instrument

 

 

907

 

 

907

 

Contingent consideration

 

 

 

(29,368

)

(29,368

)

 

Highly liquid investments with maturities of three months or less are classified as cash equivalents and are carried at cost, which approximates fair value. All investments classified as available-for-sale are recorded at fair value within short-term investments in the Consolidated Balance Sheets. The Company’s investments classified as Level 1 are based on quoted prices that are available in active markets. The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency.

 

A reconciliation of the amounts classified as Level 3 is as follows:

 

 

 

Contingent

 

 

 

Consideration

 

 

 

(in thousands)

 

Balance as of December 31, 2013

 

$

(29,368

)

Fair value adjustment

 

29,368

 

Balance as of December 31, 2014

 

$

 

 

The Company estimated the fair value of the contingent consideration by applying various probabilities and discount factors to each of the performance milestones. At December 31, 2013, contingent consideration consisted of $20.1 million and $9.3 million in current and noncurrent other liabilities, respectively, in the Consolidated Balance Sheets. During 2014, the Company determined that the agreed upon post-closing milestones were not met and reversed the fair value of the liability, which is included in “Changes in contingent consideration” in the Consolidated Statements of Operations. Refer to Note 5, “Business Combinations,” for additional information.

Investments
Investments

Note 4 — Investments

 

At December 31, 2014 and 2013 the amortized cost and fair value of marketable securities were as follows:

 

 

 

 

 

 

 

Gross

 

 

Gross

 

 

Estimated

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

 

 

 

(in thousands)

 

December 31, 2014

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

81,506

 

$

27

 

$

(6

)

$

81,527

 

Corporate debt

 

39,031

 

20

 

(6

)

39,045

 

Total available-for-sale securities

 

$

120,537

 

$

47

 

$

(12

)

$

120,572

 

 

 

 

 

 

 

 

 

 

 

December 31, 2013

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

130,956

 

$

22

 

$

(1

)

$

130,977

 

Government agency securities

 

61,004

 

9

 

 

61,013

 

Corporate debt

 

77,582

 

55

 

(36

)

77,601

 

Commercial paper

 

11,947

 

 

 

11,947

 

Total available-for-sale securities

 

$

281,489

 

$

86

 

$

(37

)

$

281,538

 

 

Available-for-sale securities in a loss position at December 31, 2014 and 2013 were as follows:

 

 

 

 

December 31, 2014

 

 

December 31, 2013

 

 

 

 

Estimated

 

 

Gross

 

 

Estimated

 

 

Gross

 

 

 

 

Fair

 

 

Unrealized

 

 

Fair

 

 

Unrealized

 

 

 

 

Value

 

 

Losses

 

 

Value

 

 

Losses

 

 

 

(in thousands)

 

U.S. treasuries

 

$

35,001

 

$

(6

)

$

29,068

 

$

(1

)

Corporate debt

 

13,069

 

(6

)

37,654

 

(36

)

Total

 

$

48,070

 

$

(12

)

$

66,722

 

$

(37

)

 

As of December 31, 2014 and 2013, there were no short-term investments that had been in a continuous loss position for more than 12 months.

 

The contractual maturities of securities classified as available-for-sale at December 31, 2014 were as follows:

 

 

 

 

December 31, 2014

 

 

 

 

 

 

 

Estimated

 

 

 

 

Amortized

 

 

Fair

 

 

 

 

Cost

 

 

Value

 

 

 

 

(in thousands)

 

Due in one year or less

 

$

74,710 

 

$

74,718 

 

Due after one year through two years

 

45,827 

 

45,854 

 

Total

 

$

120,537 

 

$

120,572 

 

 

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Realized gains for the fiscal years ended December 31, 2014 and 2013 were $0.1 million in each period, and are included in “Other, net” in the Consolidated Statements of Operations. There were minimal realized gains for the year ended December 31, 2012 and no realized losses in any of the three years.

 

Restricted Cash

 

The total amount of restricted cash at December 31, 2014 and 2013 was $0.5 million and $2.7 million, respectively, which serves as collateral for bank guarantees that provide financial assurance that the Company will fulfill certain customer obligations. This cash is held in custody by the issuing bank, and is restricted as to withdrawal or use while the related bank guarantees are outstanding.

 

Cost Method Investment

 

The Company maintains certain investments in support of its strategic business objectives, including a non-marketable cost method investment. The Company’s ownership interest is less than 20% of the investee’s voting stock, and the Company does not exert significant influence, therefore the investment is recorded at cost. The carrying value of the investment was $19.4 million and $16.9 million at December 31, 2014 and 2013, respectively and is included in “Other assets” on the Consolidated Balance Sheet. The investment is subject to a periodic impairment review; however, there are no open-market valuations, and the impairment analysis requires significant judgment. The analysis includes assessments of the investee’s financial condition, the business outlook for its products and technology, its projected results and cash flow, the likelihood of obtaining subsequent rounds of financing, and the impact of any relevant contractual equity preferences held by the Company or others. Fair value of the investment is not estimated unless there are identified events or changes in circumstances that could have a significant adverse effect on the fair value of the investment. No such events or circumstances are present.

Business Combinations
Business Combinations

Note 5 — Business Combinations

 

PSP

 

On December 4, 2014 the Company acquired 100% of Solid State Equipment, LLC (“SSEC”) and rebranded the business Veeco Precision Surface Processing (“PSP”). The results of PSP operations have been included in the consolidated financial statements since the date of acquisition. PSP designs and develops wafer wet processing capabilities. Target market applications include semiconductor advanced packaging (including 2.5D and 3D ICs), MEMS, compound semiconductor (rf, power electronics, LED and others), data storage, photomask, and flat panel displays. PSP further extends the Company’s penetration in the compound semiconductor and MEMS markets and represents the Company’s entry into the advanced packaging market.

 

The acquisition date fair value of the consideration totaled $145.5 million, net of cash acquired, which consisted of the following:

 

 

 

Acquisition Date

 

 

 

(December 4, 2014)

 

 

 

(in thousands)

 

Amount paid, net of cash acquired

 

$

145,382 

 

Working capital adjustment

 

88 

 

Acquisition date fair value

 

$

145,470 

 

 

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date. The Company utilized third-party valuations to estimate the fair value of certain of the acquired tangible and intangible assets. The values assigned to certain acquired assets and liabilities are preliminary and may be adjusted as further information becomes available during the allocation period of up to 12 months from the acquisition date.

 

 

 

Acquisition Date

 

 

 

(December 4, 2014)

 

 

 

(in thousands)

 

Accounts receivable

 

$

9,383 

 

Inventory

 

13,812 

 

Other current assets

 

463 

 

Property, plant, and equipment

 

6,912 

 

Intangible assets

 

79,810 

 

Total identifiable assets acquired

 

110,380 

 

 

 

 

 

Accounts payable and accrued expenses

 

6,473 

 

Customer deposits

 

6,039 

 

Deferred tax liability, net

 

2,705 

 

Other

 

1,089 

 

Total liabilities assumed

 

16,306 

 

 

 

 

 

Net identifiable assets acquired

 

94,074 

 

Goodwill

 

51,396 

 

Net assets acquired

 

$

145,470 

 

 

The gross contractual value of the acquired accounts receivable was approximately $10.5 million. The fair value of the accounts receivables as indicated above is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings, as well as assembled workforce. Approximately 80% of the value of the goodwill is expected to be deductible for income tax purposes.

 

The classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:

 

 

 

Acquisition Date

 

 

 

(December 4, 2014)

 

 

 

Amount

 

Useful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

39,950 

 

 

10 years

 

Customer relationships

 

34,310 

 

 

14 years

 

Backlog

 

3,340 

 

 

6 months

 

Non-compete agreements

 

1,130 

 

 

2 years

 

Trademark and tradenames

 

1,080 

 

 

1 year

 

Intangible assets acquired

 

$

79,810 

 

 

 

 

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation. The fair value of the acquired assets is provisional pending the final valuations for these assets.

 

During 2014, the Company recognized $3.2 million of acquisition related costs that are included in “Selling, general, and administrative” in the Consolidated Statements of Operations.

 

The amounts of revenue and income (loss) from continuing operations before income taxes of PSP included in the Company’s consolidated statement of operations from the acquisition date (December 4, 2014) to the period ending December 31, 2014 are as follows:

 

 

 

Total

 

 

 

(in thousands)

 

Revenue

 

$

7,906

 

Loss from operations before income taxes

 

$

(3,011

)

 

The following represents the unaudited pro forma Consolidated Statements of Operations as if PSP had been included in the Company’s consolidated results for the periods indicated. These amounts have been calculated after applying the Company’s accounting policies to material amounts and also adjusting the result of PSP to reflect the additional amortization and depreciation that would have been expensed assuming the fair value adjustments to the acquired assets had been applied on January 1, 2013:

 

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Revenue

 

$

447,089

 

$

379,272

 

Loss from operations before income taxes

 

$

(68,715

)

$

(77,252

)

 

ALD

 

On October 1, 2013 the Company acquired 100% of the outstanding common shares and voting interest of Synos Technology, Inc. and rebranded the business Veeco ALD (“ALD”). The results of ALD operations have been included in the consolidated financial statements since the date of acquisition. ALD is an early stage manufacturer of fast array scanning atomic layer deposition (“FAST-ALD”) tools for the flexible organic light-emitting diode (“OLED”) and semiconductor markets.

 

The acquisition date fair value of the consideration totaled $102.3 million, net of cash acquired, which consisted of the following:

 

 

 

Acquisition Date

 

 

 

(October 1, 2013)

 

 

 

(in thousands)

 

Cash (net of cash acquired)

 

$

71,488

 

Contingent consideration

 

33,539

 

Working capital adjustment

 

(2,695

)

Acquisition date fair value

 

$

102,332

 

 

The acquisition agreement included performance milestones that could trigger contingent payments to the original selling shareholders. During the year ended December 31, 2013, the first milestone was achieved, and the Company paid the former shareholders $5.0 million and increased the estimated fair value of the remaining contingent payments by $0.8 million. During 2014, the Company determined that all of the remaining performance milestones were not met, reversed the fair value of the liability, and recorded a non-cash gain of $29.4 million, which is included in “Changes in contingent consideration” in the Consolidated Statements of Operations.

 

During 2014, the Company finalized the working capital adjustment under the purchase agreement. Based on the final adjustment, the working capital adjustment was reduced to $1.3 million. As a result, a $1.4 million adjustment was made that increased goodwill by $0.2 million and reduced accrued expenses by $1.2 million for the relief of a potential liability that the former shareholders have retained. During 2014, the Company received payment of the $1.3 million working capital adjustment from the former shareholders, which is included in “Acquisitions of business, net of cash acquired” within the Cash Provided by Investing Activities in the Consolidated Statements of Cash Flows.

 

The following table summarizes the estimated fair value of the assets acquired and liabilities assumed at the acquisition date. The Company utilized third-party valuations to estimate the fair value of the acquired tangible and intangible assets as well as the contingent consideration:

 

 

 

Acquisition Date

 

 

 

(October 1, 2013)

 

 

 

(in thousands)

 

Accounts receivable

 

$

1,523 

 

Inventory

 

386 

 

Other current assets

 

512 

 

Property, plant, and equipment

 

1,917 

 

Intangible assets

 

99,270 

 

Total identifiable assets acquired

 

103,608 

 

 

 

 

 

Current liabilities

 

4,370 

 

Estimated deferred tax liability, net

 

32,426 

 

Total liabilities assumed

 

36,796 

 

 

 

 

 

Net identifiable assets acquired

 

66,812 

 

Goodwill

 

35,520 

 

Net assets acquired

 

$

102,332 

 

 

The goodwill is not deductible for income tax purposes.

 

The classes of intangible assets acquired and the original estimated useful life of each class is presented in the table below:

 

 

 

Acquisition Date

 

 

 

(October 1, 2013)

 

 

 

Amount

 

Uuseful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

73,160 

 

14 years

 

Customer relationships

 

20,630 

 

8 years

 

In-process research and development

 

5,070 

 

To be determined

Trademarks and trade names

 

140 

 

1 year

 

Non-compete agreement

 

270 

 

3 years

 

Intangible assets acquired

 

$

99,270 

 

 

 

 

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

 

During the fourth quarter of 2014, the Company determined that, while its ALD technology was successfully demonstrated at its key OLED display customer, it was unlikely to be adopted in the near-term for flexible OLED applications. The significant reduction in near-term forecasted bookings and cash flows required the Company to assess its ALD reporting unit for impairment. As a result, the Company recorded a non-cash impairment charge of $53.9 million related to goodwill and other long-lived assets for ALD. See Note 6, “Goodwill and Intangible Assets,” for additional information.

 

During 2013, the Company recognized $1.0 million of acquisition related costs that are included in “Selling, general, and administrative” in the Consolidated Statements of Operations.

 

The following represents the pro forma Consolidated Statements of Operations as if Veeco ALD had been included in the Company’s consolidated results for the periods indicated:

 

 

 

December 31,

 

 

 

2013

 

2012

 

 

 

(in thousands)

 

Revenue

 

  $

346,319 

 

  $

522,029 

 

Income (loss) from operations before income taxes

 

  $

(60,983)

 

  $

16,840 

 

 

These amounts have been calculated after applying the Company’s accounting policies to material amounts and also adjusting the result of ALD to reflect the additional amortization that would have been expensed assuming the fair value adjustments to the acquired assets had been applied on January 1, 2012.

Goodwill and Intangible Assets
Goodwill and Intangible Assets

Note 6 — Goodwill and Intangible Assets

 

Goodwill represents the excess of the purchase price over the sum of the amounts assigned to tangible and identifiable intangible assets acquired less liabilities assumed in each business combination. The following table presents the changes in goodwill balances during the fiscal years indicated:

 

 

 

Gross

 

 

 

 

 

 

 

Carrying

 

Accumulated

 

Net

 

 

 

Amount

 

Impairment

 

Amount

 

 

 

(in thousands)

 

As of December 31, 2012

 

$

151,069

 

$

95,241

 

$

55,828

 

Acquisition

 

35,520

 

 

35,520

 

As of December 31, 2013

 

186,589

 

95,241

 

91,348

 

Acquisition

 

51,396

 

 

51,396

 

Purchase price adjustments

 

173

 

 

173

 

Impairments

 

 

27,958

 

(27,958

)

As of December 31, 2014

 

$

238,158

 

$

123,199

 

$

114,959

 

 

Additions to the gross goodwill balance during the years ended December 31, 2014 and 2013 resulted from the acquisition of privately-held businesses as described further in Note 5, “Business Combinations.”

 

The Company performed its annual goodwill impairment test in the fourth quarter. The reporting units’ fair value exceeded their respective carrying amount and therefore goodwill within these reporting units was not impaired. The fair value of each reporting unit was determined using an income approach to determine the present value of expected future cash flows.

 

During 2014, the Company successfully demonstrated its FAST-ALD technology for flexible OLED encapsulation. But subsequent to the Company’s annual goodwill impairment test, the Company determined that the incumbent deposition technology had progressed to satisfy current market requirements. The carrying amount of the ALD reporting unit was determined to exceed its fair value, and therefore the fair value of the reporting unit’s goodwill was estimated. An impairment loss was recognized equal to the excess of the carrying amount of the reporting unit’s goodwill over its implied fair value. As part of its valuation to determine the total impairment charge, the Company also estimated the fair value of significant tangible and intangible long-lived assets within the ALD reporting unit. These tangible and intangible long-lived assets were valued using appropriate valuation techniques for assets of their nature, including income and market approaches. As a result of the impairment analysis, the Company recorded non-cash impairment charges of $28.0 million related to goodwill and $25.9 million related to other long-lived assets, including $17.4 million related to customer relationships, $4.8 million related to in-process research and development, and $3.6 million related to certain tangible assets.

 

The components of purchased intangible assets as of the dates indicated below were as follows:

 

 

 

 

 

December 31, 2014

 

December 31, 2013

 

 

 

Weighted

 

 

 

Accumulated

 

 

 

 

 

Accumulated

 

 

 

 

 

Average Remaining

 

Gross

 

Amortization 

 

 

 

Gross

 

Amortization

 

 

 

 

 

Amortization

 

Carrying

 

and

 

Net

 

Carrying

 

and

 

Net

 

 

 

Period

 

Amount

 

Impairment

 

Amount

 

Amount

 

Impairment

 

Amount

 

 

 

(in years)

 

(in thousands)

 

Technology

 

9.6

 

$

222,358 

 

$

106,342 

 

$

116,016 

 

$

182,408 

 

$

97,524 

 

$

84,884 

 

Customer relationships

 

13.9

 

69,350 

 

35,549 

 

33,801 

 

35,040 

 

14,721 

 

20,319 

 

Trademarks and tradenames

 

3.5

 

3,050 

 

1,096 

 

1,954 

 

1,970 

 

763 

 

1,207 

 

Indefinite-lived trademark

 

 

2,900 

 

 

2,900 

 

2,900 

 

 

2,900 

 

IPR&D

 

 

5,070 

 

5,070 

 

 

5,070 

 

 

5,070 

 

Other

 

1.1

 

5,485 

 

848 

 

4,637 

 

765 

 

429 

 

336 

 

Total

 

10.2

 

$

308,213 

 

$

148,905 

 

$

159,308 

 

$

228,153 

 

$

113,437 

 

$

114,716 

 

 

Other intangible assets primarily consist of patents, licenses, customer backlog, and non-compete agreements.

 

For the fiscal years ended December 31, 2014, 2013, and 2012, amortization expense for intangible assets was $13.1 million, $5.5 million, and $4.9 million, respectively. Based on the intangible assets recorded as of December 31, 2014, and assuming no subsequent additions to or impairment of the underlying assets, the remaining estimated annual amortization expense is expected to be as follows:

 

 

 

 

Amortization

 

 

 

 

(in thousands)

 

2015

 

 

$

27,003 

 

2016

 

 

20,969 

 

2017

 

 

18,100 

 

2018

 

 

16,492 

 

2019

 

 

15,235 

 

Thereafter

 

 

58,609 

 

Total

 

 

$

156,408 

 

 

Inventories
Inventories

Note 7 — Inventories

 

Inventories are stated at the lower of cost or market using standard costs that approximate actual costs on a first-in, first-out basis. Inventories consist of the following:

 

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Materials

 

$

30,319 

 

$

34,301 

 

Work-in-process

 

25,096 

 

12,900 

 

Finished goods

 

6,056 

 

12,525 

 

Total

 

$

61,471 

 

$

59,726 

 

 

Property, Plant, and Equipment
Property, Plant, and Equipment

Note 8 — Property, Plant, and Equipment and Assets Held for Sale

 

Property and equipment, net, consist of the following:

 

 

 

 

December 31,

 

 

Average

 

 

 

 

2014

 

2013

 

 

Useful Life

 

 

 

(in thousands)

 

 

 

 

Land

 

$

9,392 

 

$

12,535 

 

 

 

Building and improvements

 

51,979 

 

52,050 

 

10 – 40 years

 

Machinery and equipment

 

104,815 

 

110,228 

 

3 – 10 years

 

Leasehold improvements

 

4,356 

 

5,888 

 

3 – 7 years

 

Gross property,plant and equipment

 

170,542 

 

180,701 

 

 

 

Less: accumulated depreciation and amortization

 

91,790 

 

91,562 

 

 

 

Net property, plant, and equipment

 

$

78,752 

 

$

89,139 

 

 

 

 

Depreciation expense was $11.4 million, $12.9 million, and $11.3 million for the years ended December 31, 2014, 2013, and 2012, respectively.

 

Lab Tools

 

At December 31, 2014 and 2013, the carrying value of systems that had previously been used in the Company’s laboratories as Veeco Certified Equipment was approximately $1.3 million and $7.2 million, respectively, and was included in “Property, plant, and equipment, net” in the Consolidated Balance Sheets. These systems are being held for sale and are the same types of tools that the Company sells to its customers in the ordinary course of business. During the years ended December 31, 2014 and 2013, the Company had aggregate sales of $8.9 million and $7.4 million, respectively, of these tools with associated costs of $7.4 million and $3.7 million, respectively, which was included in “Net sales” and “Cost of sales” in the Consolidated Statements of Operations. During the years ended December 31, 2014 and 2013, the Company evaluated certain systems and reduced the carrying value of these systems that were held for sale by $0.1 million and $0.9 million, respectively, which was included in “Asset impairment” in the Consolidated Statements of Operations.

 

Assets Held for Sale

 

During the year ended December 31, 2014, the Company classified property, plant, and equipment with a carrying value of $9.5 million as assets held for sale. Using Level 2 measurement principles, the Company determined that the carrying cost of these assets exceeded the fair market value, less cost to sell, and recorded an impairment charge of approximately $3.5 million, which consisted of $1.6 million related to the Company’s research and demonstration labs in Asia and $1.9 million related to a vacant building and land. These amounts were included in “Asset impairment” in the Consolidated Statements of Operations. The net $6.0 million carrying value of these assets are included in “Assets held for sale” in the Consolidated Balance Sheet. During the year ended December 31, 2014, the Company recognized additional asset impairment charges of $0.7 million relating to assets that were abandoned during the year, which was included in “Asset impairment” in the Consolidated Statements of Operations.

Accrued Expenses and Other Liabilities
Accrued Expenses and Other Liabilities

Note 9 — Accrued Expenses and Other Liabilities

 

The components of accrued expenses and other current liabilities as of the dates indicated were as follows:

 

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Payroll and related benefits

 

$

26,605 

 

$

11,020 

 

Sales, use, and other taxes

 

1,776 

 

5,402 

 

Contingent consideration

 

 

20,098 

 

Warranty

 

5,411 

 

5,662 

 

Restructuring liability

 

1,428 

 

533 

 

Other

 

13,198 

 

8,369 

 

Total

 

$

48,418 

 

$

51,084 

 

 

Customer deposits and deferred revenue

 

Customer deposits totaled $73.0 million and $27.5 million at December 31, 2014 and 2013, respectively, which are included in “Customer deposits and deferred revenue” in the Consolidated Balance Sheets.

Discontinued Operations
Discontinued Operations

Note 10 — Discontinued Operations

 

CIGS Solar Systems Business

 

During 2011, the Company announced a plan to discontinue its CIGS solar systems business and reflected the results of operations for the CIGS solar systems business as discontinued operations.

 

Metrology

 

During 2010, the Company completed the sale of its Metrology business, except for assets located in China due to local restrictions. The Company reflected the results of operations for the Metrology business as discontinued operations and recognized a pre-tax deferred gain of $5.4 million during 2012 related to the completion of the sale of the assets in China. The Company also recognized a $1.4 million gain ($1.1 million net of taxes) on the sale of assets of this discontinued segment that were previously held for sale and sold during 2012.

 

Summary information related to discontinued operations is as follows:

 

 

 

 

2012

 

 

 

Solar

 

 

 

 

 

 

 

 

 

 

Systems

 

 

Metrology

 

 

Total

 

 

 

(in thousands)

 

Net sales

 

$

 

 

$

 

 

$

 

Net income (loss) from discontinued operations

 

$

(62

)

 

$

4,461

 

 

$

4,399

 

 

Restructuring Charges
Restructuring Charges

Note 11 — Restructuring Charges

 

Beginning in 2011 and in response to challenging business conditions, the Company initiated activities to reduce and contain spending, including reducing its workforce, consultants, and discretionary expenses.

 

During 2012, the Company recorded $3.8 million in personnel severance and related costs resulting from a headcount reduction of 52 employees. These reductions in workforce included executives, management, administration, sales and service, and manufacturing employees companywide. This consolidation was substantially complete at the end of 2012.

 

During 2013, the Company recorded $1.5 million in personnel severance and related costs resulting from the restructuring of one of its international sales offices and the consolidation of certain sales and administrative functions. This consolidation was substantially complete at the end of 2013.

 

During 2014, the Company announced the closing of its Ft. Collins, Colorado and Camarillo, California facilities. Business activities formally conducted at these sites have been transferred to the Company’s Plainview, New York facility, and the Company recorded $0.4 million of facility closing costs. The Company also took additional measures to improve profitability in the challenging business environment and notified 93 employees of their termination from the Company and recorded $4.0 million of personnel severance and related costs. These actions were substantially complete at the end of 2014. The total remaining amount expected to be incurred related to facility closing costs is approximately $0.5 million.

 

The following table shows the amounts incurred and paid for restructuring activities during the years ended December 31, 2014, 2013, and 2012 and the remaining accrued balance of restructuring costs as of December 31, 2014, which is included in “Accrued expenses and other current liabilities” in the Consolidated Balance Sheets:

 

 

 

Personnel

 

 

 

 

 

 

 

 

 

Severance and

 

 

Facility

 

 

 

 

 

 

 

Related Costs

 

 

Closing Costs

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2012

 

$

1,875

 

 

$

 

 

$

1,875

 

Provision

 

1,485

 

 

 

 

1,485

 

Payments

 

(2,827

)

 

 

 

(2,827

)

Balance at December 31, 2013

 

533

 

 

 

 

533

 

Provision

 

4,012

 

 

382

 

 

4,394

 

Payments

 

(3,117

)

 

(382

)

 

(3,499

)

Balance at December 31, 2014

 

$

1,428

 

 

$

 

 

$

1,428

 

 

Commitments and Contingencies
Commitments and Contingencies

Note 12 — Commitments and Contingencies

 

Warranty

 

Warranties are typically valid for one year from the date of system final acceptance, and the Company estimates the costs that may be incurred under the warranty. Estimated warranty costs are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and is affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs.

 

Changes in the Company’s product warranty reserves were as follows:

 

 

 

 

December 31,

 

 

 

 

2014

 

 

2013

 

 

 

(in thousands)

 

Balance, beginning of the year

 

$

5,662

 

 

$

4,942

 

Addition for new warranties issued

 

3,484

 

 

5,291

 

Addition from PSP acquisition

 

809

 

 

 

Settlements

 

(3,802

)

 

(5,580

)

Changes in estimate

 

(742

)

 

1,009

 

Balance, end of the year

 

$

5,411

 

 

$

5,662

 

 

Minimum Lease Commitments

 

Minimum lease commitments at December 31, 2014 for property and equipment under operating lease agreements (exclusive of renewal options) are payable as follows:

 

 

 

Operating

 

 

 

 

Leases

 

Payments due by period:

 

 

(in thousands)

 

2015

 

$

2,322 

 

2016

 

2,423 

 

2017

 

1,993 

 

2018

 

1,224 

 

2019

 

526 

 

Thereafter

 

2,700 

 

Total

 

$

11,188 

 

 

Rent expense was $2.3 million, $2.9 million, and $3.5 million in 2014, 2013 and 2012, respectively. In addition, the Company is obligated under such leases for certain other expenses, including real estate taxes and insurance.

 

Environmental Remediation

 

The Company is aware that petroleum hydrocarbon contamination has been detected in the soil at the site of a facility formerly leased by the Company in Santa Barbara, California. The Company has been indemnified for any liabilities that may be incurred which arise from environmental contamination at the site. Even without consideration of such indemnification, the Company does not believe that any material loss or expense is probable in connection with any such liabilities. The former owner of the land and building in Santa Barbara, California in which the Company’s former Metrology operations were located (which business was sold to Bruker Corporation (“Bruker”) on October 7, 2010), has disclosed that there are hazardous substances present in the ground under the building. Management believes that the comprehensive indemnification clause that was part of the purchase contract relating to the purchase of such land provides adequate protection against any environmental issues that may arise. The Company has provided Bruker with similar indemnification as part of the sale.

 

Legal Proceedings

 

Veeco and certain other parties were named as defendants in a lawsuit filed on April 25, 2013 in the Superior Court of California, County of Sonoma. The plaintiff in the lawsuit, Patrick Colbus, seeks unspecified damages and asserts claims that he suffered burns and other injuries while he was cleaning a molecular beam epitaxy system alleged to have been manufactured by Veeco. The lawsuit alleges, among other things, that the molecular beam epitaxy system was defective and that Veeco failed to adequately warn of the potential risks of the system. The Company believes this lawsuit is without merit and intends to defend vigorously against the claims. The Company is unable to predict the outcome of this action or to reasonably estimate the possible loss or range of loss, if any, arising from the claims asserted therein. The Company believes that, in the event of any recovery by the plaintiff from Veeco, such recovery would be fully covered by insurance.

 

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

 

Concentrations of Credit Risk

 

The Company depends on purchases from its ten largest customers, which accounted for 65% and 69% of total accounts receivable as of December 31, 2014 and 2013, respectively.

 

Customers who accounted for more than 10% of aggregate accounts receivable or net sales are as follows:

 

 

 

Accounts Receivable

 

Net Sales for the Year Ended

 

 

 

Year ended December 31,

 

December 31,

 

Customer

 

2014

 

2013

 

2014

 

2013

 

2012

 

Customer A

 

 

*

 

 

*

 

 

15%

 

 

*

 

 

*

 

Customer B

 

 

20%

 

 

10%

 

 

11%

 

 

14%

 

 

*

 

Customer C

 

 

13%

 

 

11%

 

 

*

 

 

*

 

 

*

 

Customer D

 

 

*

 

 

23%

 

 

*

 

 

*

 

 

14%

 

 

* Less than 10% of aggregate accounts receivable or net sales.

 

The Company manufactures and sells its products to companies in different geographic locations. Refer to Note 19, “Segment Reporting and Geographic Information,” for additional information. In certain instances, the Company requires deposits from its customers for a portion of the sales price in advance of shipment and performs periodic credit evaluations on its customers. Where appropriate, the Company requires letters of credit on certain non-U.S. sales arrangements. Receivables generally are due within 30 – 90 days from the date of invoice. The net accounts receivable balance is concentrated in the following geographic locations:

 

 

 

 

December 31,

 

 

 

 

2014

 

 

2013

 

 

 

(in thousands)

 

China

 

$

17,911 

 

 

$

4,130 

 

Korea

 

8,118 

 

 

2,411 

 

Thailand

 

6,324 

 

 

2,041 

 

Taiwan

 

5,838 

 

 

427 

 

Other

 

3,986 

 

 

4,890 

 

Asia Pacific

 

42,177 

 

 

13,899 

 

United States

 

13,139 

 

 

8,369 

 

EMEA and other

 

4,769 

 

 

1,555 

 

Total

 

$

60,085 

 

 

$

23,823 

 

 

Suppliers

 

The Company outsources certain functions to third parties, including the manufacture of all or substantially all of its MOCVD systems, ion beam and other data storage systems, and ion sources. The Company primarily relies on several suppliers for the manufacturing of these systems, but the Company does maintain a minimum level of internal manufacturing capability for these systems. The failure of the Company’s present suppliers to meet their contractual obligations under its supply arrangements and the Company’s inability to make alternative arrangements or resume the manufacture of these systems could have a material adverse effect on the Company’s revenues, profitability, cash flows and relationships with its customers.

 

In addition, certain of the components and sub-assemblies included in the Company’s products are obtained from a single source or a limited group of suppliers. The Company’s inability to develop alternative sources, if necessary, could result in a prolonged interruption in supply or a significant increase in the price of one or more components, which could adversely affect the Company’s operating results.

 

The Company had deposits with its suppliers of $12.7 million and $9.4 million at December 31, 2014 and 2013, respectively, that were included in “Prepaid expenses and other current assets” on the Consolidated Balance Sheets.

 

Purchase Commitments

 

The Company had purchase commitments of $112.4 million at December 31, 2014, all of which will come due within one year.

 

Bank Guarantees

 

The Company has bank guarantees issued by a financial institution on its behalf as needed. At December 31, 2014, outstanding bank guarantees totaled $45 million, of which $0.5 million is collateralized against cash that is restricted from use. As of December 31, 2014, the Company had $26 million of unused lines of credit available, which can be drawn upon to cover performance bonds required by customers.

Debt
Debt

Note 13 — Debt

 

Debt consists of a mortgage note payable with a carrying value of $1.8 million and $2.1 million as of December 31, 2014 and 2013, respectively. The mortgage note payable is secured by certain land and buildings with a carrying value of $3.3 million and $4.7 million as of December 31, 2014 and 2013, respectively. One of the buildings is currently held for sale. The annual interest rate on the mortgage is 7.91%, and the final payment is due on January 1, 2020. The Company determined the mortgage is a Level 3 liability in the fair-value hierarchy and estimated its fair value as $2.0 million and $2.3 million at December 31, 2014 and 2013, respectively, using a discounted cash flow model. Payments due under the note are as follows:

 

 

 

 

Total

 

 

 

(in thousands)

 

2015

 

$

314 

 

2016

 

340 

 

2017

 

368 

 

2018

 

398 

 

2019

 

427 

 

Total

 

1,847 

 

Less current portion

 

314 

 

Total (less current maturities)

 

$

1,533 

 

 

Derivative Financial Instruments
Derivative Financial Instruments

Note 14 — Derivative Financial Instruments

 

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rate changes could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and has not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other, net” in the Company’s Consolidated Statements of Operations. The fair value of these contracts is included in “Prepaid expenses and other current assets” in the Company’s Consolidated Balance Sheets. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk.

 

The Company did not have any outstanding derivative contracts at December 31, 2014. A summary of the foreign exchange derivatives outstanding on December 31, 2013 is as follows:

 

 

 

Fair

 

Maturity

 

Notional

 

 

 

 

Value

 

Dates

 

Amount

 

 

 

(in thousands)

 

December 31, 2013

 

 

 

 

 

 

 

Foreign currency exchange forwards

 

$

 

January 2014

 

$

4,700 

 

Foreign currency collar

 

906 

 

October 2014

 

34,069 

 

Total

 

$

907 

 

 

 

$

38,769 

 

 

The following table shows the gains and (losses) from currency exchange derivatives during the years ended December 31, 2014, 2013, and 2012, which are included in “Other, net” in the Consolidated Statements of Operations:

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

Foreign currency exchange forwards

 

$

(89

)

$

248

 

$

333

 

Foreign currency collar

 

(457

)

906

 

 

 

 

$

(546

)

$

1,154

 

$

333

 

 

Stockholders' Equity
Stockholders' Equity

Note 15 — Stockholders’ Equity

 

Accumulated Other Comprehensive Income

 

The following table presents the changes in the balances of each component of AOCI, net of tax:

 

 

 

 

Foreign

 

 

Minimum

 

 

Unrealized

 

 

 

 

 

 

 

Currency

 

 

Pension

 

 

Gains (losses) on

 

 

 

 

 

 

 

Translation

 

 

Liability

 

 

AFS Securities

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2012

 

$

6,701

 

$

(775

)

$

47

 

$

5,973

 

Other comprehensive income (loss) before reclassifications

 

(1,322

)

125

 

34

 

(1,163

)

Benefit (provision) for income taxes

 

(53

)

(86

)

11

 

(128

)

Amounts reclassified from AOCI

 

 

 

(61

)

(61

)

Other comprehensive income (loss)

 

(1,375

)

39

 

(16

)

(1,352

)

Balance at December 31, 2013

 

5,326

 

(736

)

31

 

4,621

 

Other comprehensive income (loss) before reclassifications

 

149

 

(145

)

51

 

55

 

Amounts reclassified from AOCI

 

(3,142

)

 

(65

)

(3,207

)

Other comprehensive income (loss)

 

(2,993

)

(145

)

(14

)

(3,152

)

Balance at December 31, 2014

 

$

2,333

 

$

(881

)

$

17

 

$

1,469

 

 

During the 2014, the Company completed its plan to liquidate its subsidiary in Japan, since the Company moved to a distributor model to serve its customers in that region. As a result of the liquidation, a cumulative translation gain of $3.1 million was reclassified from Other Comprehensive Income to “Other, net” on the Consolidated Statements of Operations.

 

Preferred Stock

 

The Board of Directors has authority under the Company’s Certificate of Incorporation to issue shares of preferred stock with voting and economic rights to be determined by the Board of Directors.

 

Treasury Stock

 

On August 24, 2010, the Board of Directors authorized the repurchase of up to $200 million of the Company’s common stock. All funds for this repurchase program were exhausted during fiscal year 2011, and during fiscal year 2012, the Company cancelled and retired the 5,278,828 shares of treasury stock previously purchased. During 2012 the Company recorded a reduction in treasury stock of $200.2 million and a corresponding reduction of $200.1 million and $0.1 million in retained earnings and common stock, respectively.

Stock Plans
Stock Plans

Note 16 — Stock Plans

 

Share-based incentive awards are provided to employees under the terms of the Company’s equity incentive compensation plans (the “Plans”). During 2010 the Company’s Board of Directors approved the 2010 Stock Incentive Plan (as amended to date, the “2010 Plan”), which replaced the 2000 Stock Incentive Plan, as amended (the “2000 Plan”). The Plans are administered by the Compensation Committee of the Board of Directors. The Company’s employees, non-employee directors, and consultants are eligible to receive awards under the 2010 Plan, which can include non-qualified stock options, incentive stock options, restricted share awards (“RSAs”), restricted share units (“RSUs”), share appreciation rights, dividend equivalent rights or any combination thereof. The Company typically settles awards under the Plans with newly issued shares. All Plans, with the exception of acquired companies’ stock plans, have been approved by the Company’s shareholders.

 

The Board of Directors granted equity awards to certain employees in connection with the Company’s acquisition of ALD during fiscal year 2013 (Refer to Note 5, “Business Combinations” for additional information on the acquisition). The equity awards were granted under the Company’s 2013 Inducement Stock Incentive Plan (the “Inducement Plan”), which the Board of Directors adopted to facilitate the granting of equity awards as an inducement to these employees to commence employment with the Company. The Company issued 124,500 stock option shares and 87,000 RSUs under this plan. The stock options will vest over a three year period and have a 10-year term, and the RSUs will vest over a two or four year period. As of December 31, 2013, the Inducement Plan was merged into the 2010 Plan and is considered an inactive plan with no further shares available for grant. As of December 31, 2014, there are 124,500 option shares and 82,700 RSUs outstanding under the Inducement Plan.

 

The Company is authorized to issue up to 6.8 million shares under the 2010 Plan, including additional shares authorized under a 2013 plan amendment approved by shareholders. Option awards are generally granted with an exercise price equal to the closing price of the Company’s common stock on the trading day prior to the date of grant; option awards generally vest over a three year period and have a seven or ten year term. RSAs and RSUs generally vest over one to five years. Certain option and share awards provide for accelerated vesting if there is a change in control, as defined in the 2010 Plan. As of December 31, 2014, there are 1.9 million option shares and 0.4 million RSUs outstanding under the 2010 Plan.

 

The 2000 Plan was approved by the Company’s Board of Directors and shareholders in fiscal year 2000 and was replaced by the 2010 Plan. Therefore, no additional awards are made under this plan. Stock awards granted pursuant to the 2000 Plan expire after seven years and generally vest over a two to five year period. As of December 31, 2014, there are 0.4 million option shares outstanding under the 2000 Plan.

 

Shares Reserved for Future Issuance

 

At December 31, 2014, the Company has 4.9 million shares reserved to cover exercises of outstanding stock options, vesting of RSUs, and additional grants under the 2010 Plan.

 

Share-Based Compensation

 

The Company recognized share-based compensation in the following line items in the Consolidated Statements of Operations for the periods indicated:

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

 

 

(in thousands)

 

 

 

Cost of sales

 

$

2,456

 

$

1,446

 

$

1,467

 

Selling, general, and administrative

 

11,859

 

8,339

 

9,677

 

Research and development

 

4,498

 

3,347

 

2,709

 

Share-based compensation expense before tax

 

18,813

 

13,132

 

13,853

 

Income tax benefit

 

(6,011

)

(4,367

)

(4,849

)

Net share-based compensation expense

 

$

12,802

 

$

8,765

 

$

9,004

 

 

The Company capitalized an insignificant amount of share-based compensation into inventory for the years ended December 31, 2014, 2013, and 2012.

 

The following table summarizes information about unrecognized share-based compensation costs at December 31, 2014:

 

 

 

Unrecognized

 

Weighted

 

 

 

Share-Based

 

Average Period

 

 

 

Compensation

 

Expected to be

 

 

 

Costs

 

Recognized

 

 

 

(in thousands)

 

(in years)

 

Stock option awards

 

$

9,939 

 

2.0 

 

Restricted stock units

 

9,980 

 

2.5 

 

Restricted stock awards

 

17,501 

 

2.8 

 

Performance share units

 

2,855 

 

3.3 

 

Performance share awards

 

152 

 

0.4 

 

Total unrecognized share-based compensation cost

 

$

40,427 

 

2.5 

 

 

Stock Option Awards

 

Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2014, options outstanding that have vested and are expected to vest were as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Number

 

Weighted

 

Average

 

Aggregate

 

 

 

of

 

Average

 

Remaining

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Contractual Life

 

Value

 

 

 

(in thousands)

 

 

 

(in years)

 

(in thousands)

 

Vested

 

1,409 

 

$

30.76 

 

5.2 

 

$

10,127 

 

Expected to vest

 

903 

 

$

32.93 

 

7.7 

 

2,091 

 

Total

 

2,312 

 

$

31.61 

 

6.2 

 

$

12,218 

 

 

Outstanding options expected to vest are net of estimated future forfeitures. The aggregate intrinsic value represents the difference between the option exercise price and $34.88, the closing price of the Company’s common stock on December 31, 2014, the last trading day of the Company’s fiscal year as reported on The NASDAQ Stock Market for all in-the-money options.

 

Additional information with respect to stock option activity was as follows:

 

 

 

 

 

Weighted

 

 

 

Number of

 

Average

 

 

 

Shares

 

Exercise Price

 

 

 

(in thousands)

 

 

 

Outstanding at December 31, 2011

 

2,106

 

$

25.58

 

Granted

 

704

 

32.55

 

Exercised

 

(351

)

15.39

 

Expired or forfeited

 

(137

)

35.88

 

Outstanding at December 31, 2012

 

2,322

 

$

28.63

 

Granted

 

539

 

32.68

 

Exercised

 

(149

)

14.74

 

Expired or forfeited

 

(114

)

35.22

 

Outstanding at December 31, 2013

 

2,598

 

$

29.98

 

Granted

 

509

 

33.05

 

Exercised

 

(561

)

23.88

 

Expired or forfeited

 

(155

)

36.22

 

Outstanding at December 31, 2014

 

2,391

 

$

31.65

 

 

The following table summarizes stock option information at December 31, 2014:

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Aggregate

 

Average

 

Weighted

 

 

 

Aggregate

 

Average

 

Weighted

 

Range of

 

 

 

Intrinsic

 

Remaining

 

Average

 

 

 

Intrinsic

 

Remaining

 

Average

 

Exercise Prices

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

$8.82 – $17.48

 

386 

 

$

8,769 

 

1.3 

 

$

12.15 

 

386 

 

$

8,769 

 

1.3 

 

$

12.15 

 

$20.80 – $31.45

 

347 

 

1,626 

 

8.8 

 

30.20 

 

125 

 

616 

 

8.7 

 

29.94 

 

$31.91 – $48.04

 

1,429 

 

2,000 

 

6.9 

 

34.14 

 

669 

 

742 

 

6.4 

 

34.63 

 

$48.90 – $51.70

 

229 

 

 

6.4 

 

51.21 

 

229 

 

 

6.4 

 

51.21 

 

 

 

2,391 

 

$

12,395 

 

6.2 

 

$

31.65 

 

1,409 

 

$

10,127 

 

5.2 

 

$

30.76 

 

 

The fair value of each option is estimated on the date of grant using the Black-Scholes option pricing model. Estimates of fair value are not intended to predict actual future events or the value ultimately realized by employees who receive equity awards. The weighted average estimated values of employee stock option grants as well as the weighted average assumptions that were used in calculating such values during fiscal years 2014, 2013, and 2012 were based on estimates at the date of grant as follows:

 

 

 

Year ended December 31,

 

 

2014

 

2013

 

2012

Weighted average fair value

 

$

11.58 

 

$

13.47 

 

$

15.56 

Dividend yield

 

%

 

%

 

%

Expected volatility factor(1)

 

44 

%

 

49 

%

 

59 

%

Risk-free interest rate(2)

 

1.19 

%

 

1.27 

%

 

0.70 

%

Expected life(in years)(3)

 

3.9 

 

4.5 

 

4.5 

 

(1)

Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term of the options and the implied volatility derived from the market prices of the Company’s traded opt ions.

 

(2)

The risk-free rate for periods within the contractual term of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant.

 

(3)

The expected life is the number of years the Company estimates that options will be out standing prior to exercise. The Company’s computation of expected life was determined using a lattice-based model incorporating historical post vest exercise and employee termination behavior.

 

The following table summarizes information on options exercised for the periods indicated:

 

 

 

Year ended December 31,

 

 

2014

 

2013

 

2012

 

 

 

 

(in thousands)

 

 

Cash received from options exercised

 

$

12,056 

 

$

2,199 

 

$

5,409 

Intrinsic value of options exercised

 

$

8,390 

 

$

2,509 

 

$

6,800 

 

RSAs and RSUs

 

RSAs are stock awards issued to employees that are subject to specified restrictions and a risk of forfeiture. RSAs entitle holders to dividends. The restrictions typically lapse over one to five years. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant. RSUs are stock awards issued to employees that entitle the holder to receive shares of common stock as the awards vest, typically over one to five years. RSUs do not entitle holders to dividends. The fair value of the awards is determined and fixed based on the closing price of the Company’s common stock on the trading day prior to the date of grant reduced by the present value of dividends expected to be paid on the Company’s stock prior to vesting of the RSUs, which is currently assumed to be zero.

 

The following table summarizes the activity of RSAs and RSUs under the Plans:

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

Number of

 

Grant Date

 

 

 

Shares

 

Fair Value

 

 

 

(in thousands)

 

 

 

Outstanding at December 31, 2011

 

618

 

$

33.61

 

Granted

 

324

 

32.62

 

Released

 

(167

)

20.60

 

Forfeitures

 

(82

)

34.98

 

Outstanding at December 31, 2012

 

693

 

$

36.11

 

Granted

 

798

 

33.16

 

Released

 

(207

)

32.44

 

Forfeitures

 

(126

)

34.33

 

Outstanding at December 31, 2013

 

1,158

 

$

34.93

 

Granted

 

395

 

34.18

 

Released

 

(183

)

38.65

 

Forfeitures

 

(133

)

33.66

 

Outstanding at December 31, 2014

 

1,237

 

$

34.27

 

 

Released shares include the impact of restricted stock shares that were cancelled due to elections by employees to cover withholding taxes with such shares. The total fair value of shares that vested during the years ended December 31, 2014, 2013, and 2012 was $6.2 million, $7.9 million, and $5.4 million, respectively.

Retirement Plans
Retirement Plans

Note 17 — Retirement Plans

 

The Company maintains a defined contribution plan for the benefit of its U.S. employees. The plan is intended to be tax qualified and contains a qualified cash or deferred arrangement as described under Section 401(k) of the Internal Revenue Code. Eligible participants may elect to contribute a percentage of their base compensation, and the Company may make matching contributions, generally equal to fifty cents for every dollar employees contribute, up to the lesser of three percent of the employee’s eligible compensation or three percent of the maximum the employee is permitted to contribute under then current Internal Revenue Code limitations. Generally, the plan calls for vesting in the Company contributions over the initial five years of a participant’s employment. The Company maintains a similar type of contribution plan at one of its foreign subsidiaries. The Company recognized costs associated with these plans of approximately $1.9 million, $2.3 million, and $2.5 million for fiscal years 2014, 2013, and 2012, respectively.

 

The Company acquired a defined benefit plan in fiscal year 2000 that had been frozen as of September 30, 1991, and no further benefits have been accrued by participants since that date. All participants are fully vested in their respective benefits. The plan year end is September 30 and is subject to the provisions of the Employee Retirement Income Security Act of 1974. At September 30, 2014, the plan had 73 participants and $1.5 million in contract assets.

Income Taxes
Income Taxes

Note 18 — Income Taxes

 

The amounts of income from continuing operations before income taxes attributable to domestic and foreign operations were as follows:

 

 

 

Year ended December 31,

 

 

 

2014

 

 

2013

 

 

2012

 

 

 

 

 

 

(in thousands)

 

 

 

 

Domestic

 

$

(95,195

)

 

$

(84,942

)

 

$

5,811

 

Foreign

 

16,841

 

 

13,732

 

 

32,375

 

 

 

$

(78,354

)

 

$

(71,210

)

 

$

38,186

 

 

Significant components of the provision (benefit) for income taxes from continuing operations consisted of the following:

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

 

 

(in thousands)

 

 

 

Current:

 

 

 

 

 

 

 

Federal

 

$

(2,464

)

$

(21,022

)

$

2,515

 

Foreign

 

2,325

 

3,921

 

7,576

 

State and local

 

55

 

148

 

(317

)

Total current provision (benefit) for income taxes

 

(84

)

(16,953

)

9,774

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(11,230

)

(11,589

)

(482

)

Foreign

 

(291

)

(462

)

727

 

State and local

 

191

 

57

 

1,638

 

Total deferred provision (benefit) for income taxes

 

(11,330

)

(11,994

)

1,883

 

Total provision (benefit) for income taxes

 

$

(11,414

)

$

(28,947

)

$

11,657

 

 

The income tax expense from continuing operations was reconciled to the tax expense computed at the U.S. federal statutory tax rate as follows:

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

 

 

(in thousands)

 

 

 

Income tax provision (benefit) at U.S. statutory rates

 

$

(27,424

)

$

(24,923

)

$

13,366

 

State taxes, net of U.S. federal impact

 

(662

)

(1,554

)

(89

)

Effect of international operations

 

(6,160

)

(4,275

)

(2,387

)

Domestic production activities deduction

 

 

1,554

 

(489

)

Research and development tax credit

 

(1,935

)

(3,151

)

(3,013

)

Net change in valuation allowance

 

27,156

 

2,420

 

2,943

 

Change in accrual for unrecognized tax benefits

 

(1,940

)

577

 

533

 

Goodwill impairment

 

9,786

 

 

 

Change in contingent consideration

 

(10,279

)

290

 

 

Other

 

44

 

115

 

793

 

Total provision (benefit) for income taxes

 

$

(11,414

)

$

(28,947

)

 $

11,657

 

 

The Company entered into an agreement during the fourth quarter of fiscal year 2014 that concludes that it will receive a tax incentive pursuant to a negotiated tax holiday for the period from August 1, 2010 through July 31, 2014 in one of its foreign subsidiaries. As such, the Company reversed a $4.9 million tax liability, which represents the cumulative effect of calculating the tax provision using the incentive tax rate as compared to the foreign country’s statutory rate through the end of 2013.

 

In connection with the acquisition of PSP, the Company recorded a $2.7 million deferred tax liability related to the difference between the basis of assets acquired as calculated for financial reporting purposes as compared with the basis of assets acquired as calculated for income tax purposes. Refer to Note 5, “Business combinations” for additional information on the acquisition of PSP.

 

The Company did not record any excess tax benefits related to share-based compensation in 2014 or 2013, which would have been $0.6 million and $0.5 million, respectively. In the future, the Company will record the excess tax benefits to additional paid-in capital for financial reporting purposes when the net operating losses for excess tax benefits are utilized and reduce the Company’s current taxes payable. During 2012, the tax benefit from share-based incentive awards that was deductible for tax purposes exceeded that which was recorded for financial reporting purposes by $2.1 million and was recorded to “Additional paid-in capital” in the Consolidated Balance Sheets.

 

Deferred income taxes reflect the effect of temporary differences between the carrying amounts of assets and liabilities recognized for financial reporting purposes and the amounts recognized for tax purposes. The tax effects of the temporary differences were as follows:

 

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

Inventory valuation

 

$

8,244

 

$

6,983

 

Net operating losses and credit carry forwards

 

39,750

 

18,972

 

Warranty and installation accruals

 

2,452

 

3,002

 

Share-based compensation

 

11,794

 

10,638

 

Other

 

2,647

 

3,716

 

Total deferred tax assets

 

64,887

 

43,311

 

Valuation allowance

 

(34,909

)

(7,753

)

Net deferred tax assets

 

29,978

 

35,558

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Purchased intangible assets

 

34,018

 

45,208

 

Undistributed earnings

 

1,047

 

1,737

 

Depreciation

 

2,274

 

4,711

 

Total deferred tax liabilities

 

37,339

 

51,656

 

Net deferred taxes

 

$

(7,361

)

$

(16,098

)

 

The Company did not make a provision for U.S. federal income taxes or additional withholding taxes on amounts invested in foreign subsidiaries in the amounts of $115.8 million and $101.0 million at December 31, 2014 and 2013, respectively, since such amounts are indefinitely reinvested. As such, it is not practicable to determine the amount of tax associated with such unremitted earnings. For financial reporting purposes, these balances are determined as amounts that exceed the tax basis of such investments. The Company has provided U.S. federal income taxes and additional withholding taxes on foreign earnings that are anticipated to be remitted.

 

As of December 31, 2014, the Company had U.S. federal net operating loss carryforwards of approximately $53.3 million that will expire between 2031 and 2034, if not utilized. As of December 31, 2014, the Company had U.S. foreign tax credit carryforwards of $7.0 million that will expire between 2023 and 2024 and U.S. federal research and development credits of $9.2 million that will expire between 2031 and 2034. The Company also has state and local net operating losses and credit carryforwards.

 

The Company makes assessments to estimate if sufficient taxable income will be generated in the future to use existing deferred tax assets. The Company’s cumulative three year loss in its domestic operations led to a full valuation allowance against the Company’s U.S. deferred tax assets, since the Company could not conclude that such amounts are realizable on a more-likely-than-not basis. As such, the Company increased the valuation allowance by approximately $27.2 million at December 31, 2014.

 

The Company may amortize indefinite-lived intangible assets for tax purposes, which are not amortizable for financial reporting purposes. The deferred tax liability at December 31, 2014 relates to the tax effect of differences between financial reporting and tax bases of intangible assets that are not expected to reverse within the Company’s net operating loss carryforward period.

 

A roll-forward of the Company’s uncertain tax positions for all U.S. federal, state, and foreign tax jurisdictions was as follows:

 

 

 

December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

Balance at beginning of year

 

$

6,228

 

$

5,818

 

$

4,748

 

Additions for tax positions related to current year

 

244

 

324

 

435

 

Additions for tax positions related to prior years

 

199

 

477

 

742

 

Reductions for tax positions related to prior years

 

(2,345

)

(224

)

(59

)

Reductions due to the lapse of the applicable statute of limitations

 

(38

)

 

(48

)

Settlements

 

(12

)

(167

)

 

Balance at end of year

 

$

4,276

 

$

6,228

 

$

5,818

 

 

The amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate was $4.3 million and $6.2 million at December 31, 2014 and 2013, respectively. The gross amount of interest and penalties accrued in income tax payable in the Consolidated Balance Sheets was approximately $0.3 million and $0.8 million at December 31, 2014 and 2013, respectively.

 

The Company or one of its subsidiaries files income tax returns in the United States federal jurisdiction and various states, local, and foreign jurisdictions. All material federal income tax matters have been concluded for years through 2010 subject to subsequent utilization of net operating losses generated in such years. The recently settled 2010 IRS examination resulted in the reversal of approximately $2.3 million of liabilities relating to uncertain tax positions. The 2011 federal tax return is currently under examination. All material state and local income tax matters have been reviewed through 2008. The majority of the Company’s foreign jurisdictions have been reviewed through 2009. Principally all of the Company’s foreign jurisdictions remain open with respect to the tax years from 2010 through 2014. The Company does not anticipate that its uncertain tax position will change significantly within the next twelve months subject to the completion of the ongoing federal tax audit and any resultant settlement.

Segment Reporting and Geographic Information
Segment Reporting and Geographic Information

Note 19 — Segment Reporting and Geographic Information

 

The Company operates and measures its results in one operating segment and therefore has one reportable segment: the design, development, manufacture, and support of thin film process equipment primarily sold to make electronic devices. The Company’s Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding allocation of resources based on total Company results.

 

Revenue by major class of product is as follows:

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

MOCVD

 

$

279,751 

 

$

219,914 

 

$

314,152 

 

MBE

 

28,033 

 

29,419 

 

49,029 

 

Surface Processing

 

7,906 

 

 

 

Ion Beam and other

 

77,183 

 

82,416 

 

152,839 

 

Total Revenue

 

$

392,873 

 

$

331,749 

 

$

516,020 

 

 

The Company’s significant operations outside the United States include sales and service offices in Asia-Pacific and Europe. For geographic reporting, revenues are attributed to the location in which the customer facility is located. Revenue and long-lived tangible assets by geographic region is as follows:

 

 

 

Net Sales to Unaffiliated Customers

 

Long-Lived Tangible Assets

 

 

 

2014

 

2013

 

2012

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

United States

 

$

44,060 

 

$

57,609 

 

$

83,317 

 

$

63,349 

 

$

66,002 

 

$

74,497 

 

Asia Pacific(1)

 

311,182 

 

252,199 

 

390,995 

 

15,325 

 

23,042 

 

23,769 

 

EMEA(2) and other

 

37,631 

 

21,941 

 

41,708 

 

78 

 

95 

 

36 

 

Total

 

$

392,873 

 

$

331,749 

 

$

516,020 

 

$

78,752 

 

$

89,139 

 

$

98,302 

 

 

(1)

Net sales to customers in China were 40%, 45%, and 42% of total net sales for the years ended December 31, 2014, 2013, 2012, respectively.

 

(2)

Consists of Europe, the Middle East, and Africa

 

Selected Quarterly Financial Information (unaudited)
Selected Quarterly Financial Information (unaudited)

Note 20 — Selected Quarterly Financial Information (unaudited)

 

The following table presents selected unaudited financial data for each fiscal quarter of 2014 and 2013. Although unaudited, this information has been prepared on a basis consistent with the Company’s audited Consolidated Financial Statements and, in the opinion of management, reflects all adjustments (consisting only of normal recurring adjustments) that are considered necessary for a fair presentation of this information in accordance with GAAP. Such quarterly results are not necessarily indicative of future results of operations.

 

 

 

Fiscal 2014

 

Fiscal 2013

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Q1

 

Q2

 

Q3

 

Q4

 

 

 

(in thousands, except per share amounts)

Net sales

 

$

90,841 

 

$

95,122 

 

$

93,341 

 

$

113,569 

 

$

61,781 

 

$

97,435 

 

$

99,324 

 

$

73,209 

 

Gross profit

 

$

33,777 

 

$

30,673 

 

$

 

32,558 

 

$

37,874 

 

$

22,552 

 

$

34,640 

 

$

30,308 

 

$

15,642 

 

Net income (loss)

 

$

19,160 

 

$

(15,211)

 

$

 

(13,977)

 

$

(56,912)

 

$

(10,071)

 

$

(4,081)

 

$

(6,026)

 

$

(22,085)

 

Basic income (loss) per common share

 

$

0.49 

 

$

(0.39)

 

$

 

(0.35)

 

$

(1.44)

 

$

(0.26)

 

$

(0.11)

 

$

(0.16)

 

$

(0.57)

 

Diluted income (loss) per common share

 

$

0.48 

 

$

(0.39)

 

$

 

(0.35)

 

$

(1.44)

 

$

(0.26)

 

$

(0.11)

 

$

(0.16)

 

$

(0.57)

 

 

Impairment Charge

 

During the fourth quarter of 2014, the Company recorded a non-cash asset impairment charge of $53.9 million related to its ALD reporting unit. Refer to Note 6, “Goodwill and Intangible Assets,” for additional information.

 

Acquisition of PSP

 

During the fourth quarter of 2014, the Company acquired PSP. The results of operations of PSP have been included in the consolidated financial statements since that date. Refer to Note 5, “Business Combinations,” for additional information.

 

Change in Contingent Consideration

 

During the first quarter of 2014, the Company recorded a non-cash gain of $29.4 million related to a change in the Company’s assessment of potential future payments related to its ALD reporting unit. Refer to Note 5, “Business Combinations,” for additional information.

 

Acquisition of ALD

 

During the fourth quarter of 2013, the Company acquired ALD. The results of operations of ALD have been included in the consolidated financial statements since that date. Refer to Note 5, “Business Combinations,” for additional information.

Schedule II-Valuation and Qualifying Accounts
Schedule II-Valuation and Qualifying Accounts

Schedule II — Valuation and Qualifying Accounts

 

 

 

 

 

Additions

 

 

 

 

 

 

 

 

 

Charged

 

 

 

 

 

 

 

 

 

Balance at

 

(Credited)

 

Charged to

 

 

 

Balance at

 

 

 

Beginning

 

to Costs and

 

Other

 

 

 

End of

 

Description

 

of Period

 

Expenses

 

Accounts

 

Deductions

 

Period

 

Deducted from asset accounts:

 

 

 

 

 

(in thousands)

 

 

 

 

 

Year ended December 31, 2014

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

2,438

 

$

(1,814

)

$

325

 

$

(218

)

$

731

 

Valuation allowance in net deferred tax assets

 

7,753

 

27,156

 

 

 

34,909

 

 

 

$

10,191

 

$

25,342

 

$

325

 

$

(218

)

$

35,640

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

492

 

$

1,946

 

$

 

$

 

$

2,438

 

Valuation allowance in net deferred tax assets

 

4,708

 

2,420

 

625

 

 

7,753

 

 

 

$

5,200

 

$

4,366

 

$

625

 

$

 

$

10,191

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful accounts

 

$

468

 

$

198

 

$

 

$

(174

)

$

492

 

Valuation allowance in net deferred tax assets

 

1,765

 

2,943

 

 

 

4,708

 

 

 

$

2,233

 

$

3,141

 

$

 

$

(174

)

$

5,200

 

 

Significant Accounting Policies (Policies)

(b) Basis of Presentation

 

The accompanying audited Consolidated Financial Statements of the Company have been prepared in accordance with United States generally accepted accounting principles (GAAP). The Company reports interim quarters on a 13-week basis ending on the last Sunday of each period, which is determined at the start of each year. The Company’s fourth quarter always ends on the last day of the calendar year, December 31. During 2014 the interim quarters ended on March 30, June 29 and September 28, and during 2013 the interim quarters ended on March 31, June 30 and September 29. The Company reports these interim quarters as March 31, June 30 and September 30 in its interim consolidated financial statements.

(c) Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, these estimates may ultimately differ from actual results. Significant items subject to such estimates and assumptions include: (i) the best estimate of selling price for the Company’s products and services; (ii) allowances for doubtful accounts and inventory obsolescence; (iii) the useful lives and expected future cash flows of property, plant, and equipment and identifiable intangible assets; (iv) the fair value of the Company’s reporting units and related goodwill; (v) the fair value, less cost to sell, of assets held for sale; (vi) investment valuations and the valuation of derivatives, deferred tax assets, and assets acquired in business combinations; (vii) the recoverability of long lived assets; (viii) liabilities for product warranty and legal contingencies; (ix) share-based compensation; and (x) income tax uncertainties. Actual results could differ from those estimates.

(d) Principles of Consolidation

 

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Companies acquired during each reporting period are reflected in the results of the Company effective from their respective dates of acquisition through the end of the reporting period.

(e) Foreign Currencies

 

Assets and liabilities of the Company’s foreign subsidiaries that operate using local functional currencies are translated using the exchange rates in effect at the balance sheet date. Results of operations are translated using monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s subsidiaries into U.S. dollars, including intercompany transactions of a long-term nature, are reported as currency translation adjustments in “Accumulated other comprehensive income” in the Consolidated Balance Sheets. Foreign currency transaction gains or losses are included in “Other, net” in the Consolidated Statements of Operations.

(f) Revenue Recognition

 

The Company recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists with a customer; delivery of the specified products has occurred or services have been rendered; prices are contractually fixed or determinable; and collectability is reasonably assured. Revenue is recorded including shipping and handling costs and excluding applicable taxes related to sales. A significant portion of the Company’s revenue is derived from contractual arrangements with customers that have multiple elements, such as systems, upgrades, components, spare parts, maintenance, and service plans. For sales arrangements that contain multiple elements, the arrangement is split into separate units of accounting if the individually delivered elements have value to the customer on a standalone basis. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a multiple element arrangement, based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. When there are separate units of accounting, the Company allocates revenue to each element based on the following selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; or the best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. The Company uses BESP for the majority of the elements in its arrangements.

 

The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition including its contractual obligations, the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majority of the arrangements, a customer source inspection of the system is performed in the Company’s facility or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. As such, the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery and, therefore, revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below. For new products, new applications of existing products or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred and fully recognized upon the receipt of final customer acceptance, assuming all other revenue recognition criteria have been met.

 

The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; that is, it does not require significant changes to the features or capabilities of the equipment or involve building elaborate interfaces or connections subsequent to factory acceptance. The Company has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage the Company to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, the Company accrues the cost of the installation at the time of revenue recognition for the system.

 

In many cases the Company’s products are sold with a billing retention, typically 10% of the sales price (the “retention amount”), which is typically payable by the customer when field acceptance provisions are completed. The amount of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount billed that is not contingent upon acceptance provisions or ii) the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.

 

The Company’s contractual terms with customers in Japan generally specify that title and risk and rewards of ownership transfer upon customer acceptance. As a result, for customers in Japan, revenue is recognized upon the receipt of written customer acceptance. During the fourth quarter of fiscal 2013, the Company began using a distributor for almost all of its product and service sales to customers in Japan. Title passes to the distributor upon shipment, however, due to customary local business practices, the risk and rewards of ownership of the system transfers to the end-customers upon their acceptance. As such, the Company recognizes revenue upon receipt of written acceptance from the end customer.

 

The Company recognizes revenue related to maintenance and service contracts ratably over the applicable contract term. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at the time of delivery in accordance with the terms of the applicable sales arrangement.

 

Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred, even if the related revenue is deferred in accordance with the above policy.

(g) Warranty Costs

 

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance by providing labor and parts necessary to repair the systems during the warranty period. The Company accounts for the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of sales” in the Consolidated Statements of Operations. The estimated warranty cost is based on the Company’s historical experience with its systems and regional labor costs. The Company calculates the average service hours by region and parts expense per system utilizing actual service records to determine the estimated warranty charge. The Company updates its warranty estimates on a semiannual basis when the actual product performance and/or field expense differs from original estimates.

(h) Shipping and Handling Costs

 

Shipping and handling costs are expenses incurred to move, package and prepare the Company’s products for shipment and to move the products to a customer’s designated location. These costs are generally comprised of payments to third-party shippers. Shipping and handling costs are included in “Cost of sales” in the Consolidated Statements of Operations.

(i) Research and Development Costs

 

Research and development costs are expensed as incurred and include charges for the development of new technology and the transition of existing technology into new products or services.

(j) Advertising Expense

 

The cost of advertising is expensed as incurred and totaled $0.6 million, $0.5 million, and $0.8 million during 2014, 2013 and 2012, respectively.

(k) Accounting for Share-Based Compensation

 

Share-based awards exchanged for employee services are accounted for under the fair value method. Accordingly, share-based compensation cost is measured at the grant date based on the fair value of the award. The expense for awards expected to vest is recognized over the employee’s requisite service period (generally the vesting period of the award). Awards expected to vest are estimated based on a combination of historical experience and future expectations.

 

The Company has elected to treat awards with only service conditions and with graded vesting as one award. Consequently, the total compensation expense is recognized straight-line over the entire vesting period, so long as the compensation cost recognized at any date at least equals the portion of the grant date fair value of the award that is vested at that date.

 

The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards. The Black-Scholes model includes assumptions regarding dividend yields, expected volatility, expected option term, and risk-free interest rates. See Note 16, “Stock Plans,” for additional information.

 

In addition to stock options, restricted share awards (“RSAs”) and restricted stock units (“RSUs”) with time-based vesting, the Company issues performance share units and awards (“PSUs” and “PSAs”). Compensation cost for PSUs and PSAs is recognized over the requisite service period based on the timing and expected level of achievement of the performance targets. A change in the assessment of the probability of a performance condition being met is recognized in the period of the change in estimate. At the conclusion of the performance period, the applicable number of shares of RSAs, RSUs, or unrestricted shares granted may vary based on the level of achievement of the performance targets.

(l) Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities from a change in tax rate is recognized in income in the period that includes the enactment date.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to uncertain tax positions in income tax expense. See Note 18, “Income Taxes,” for additional information.

(m) Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, derivative financial instruments used in hedging activities, and accounts receivable. The Company invests in a variety of financial instruments and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material credit losses on its investments.

 

The Company maintains an allowance reserve for potentially uncollectible accounts for estimated losses resulting from the inability of its customers to make required payments. The Company evaluates its allowance for doubtful accounts based on a combination of factors. In circumstances where specific invoices are deemed to be uncollectible, the Company provides a specific allowance for bad debt against the amount due to reduce the net recognized receivable to the amount reasonably expected to be collected. The Company also provides allowances based on its write-off history. The allowance for doubtful accounts totaled $0.7 million and $2.4 million at December 31, 2014 and 2013, respectively.

 

To further mitigate the Company’s exposure to uncollectable accounts, the Company may request certain customers provide a negotiable irrevocable letter of credit drawn on a reputable financial institution. These irrevocable letters of credit are typically issued to mature between zero and 90 days from the date the documentation requirements are met, typically when a system ships or upon receipt of final acceptance from the customer. The Company, at its discretion, may monetize these letters of credit on a non-recourse basis after they become negotiable, but before maturity. The fees associates with the monetization are included in “Selling, general, and administrative” in the Consolidated Statements of Operations and were insignificant for the fiscal years ended December 31, 2014, 2013, and 2012.

(n) Fair Value of Financial Instruments

 

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses reflected in the consolidated financial statements approximate fair value due to their short-term maturities. The fair value of debt for footnote disclosure purposes, including current maturities, is estimated using a discounted cash flow analysis based on the estimated current incremental borrowing rates for similar types of securities.

(o) Cash, Cash Equivalents, and Short-Term Investments

 

All financial instruments purchased with an original maturity of three months or less at the time of purchase are considered cash equivalents. Such items may include liquid money market accounts, U.S. treasuries, government agency securities, and corporate debt. Investments that are classified as cash equivalents are carried at cost, which approximates fair value.

 

A portion of the Company’s cash and cash equivalents is held by its subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which may not be the U.S. dollar. Approximately 81% and 71% of cash and cash equivalents were maintained outside the United States at December 31, 2014 and 2013, respectively.

 

Marketable securities are generally classified as available-for-sale for use in current operations, if required, and are reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income.” These securities can include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other, net” in the Consolidated Statements of Operations. The specific identification method is used to determine the realized gains and losses on investments.

(p) Inventories

 

Inventories are stated at the lower of cost or market, with cost determined on a first-in, first-out basis. The Company reviews and sets standard costs on a periodic basis at current manufacturing costs in order to approximate actual costs. The Company assesses the valuation of all inventories, including manufacturing raw materials, work-in-process, finished goods, and spare parts, each quarter. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general market conditions, possible alternative uses, and ultimate realization of excess inventory. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. See Note 5, “Business Combinations,” for additional information.

(q) Business Combinations

 

The Company allocates the fair value of the purchase consideration of the Company’s acquisitions to the tangible assets, intangible assets, including in-process research and development (“IPR&D”), if any, and liabilities assumed, based on estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. IPR&D is initially capitalized at fair value as an intangible asset with an indefinite life and assessed for impairment thereafter. When a project underlying reported IPR&D is completed, the corresponding amount of IPR&D is amortized over the asset’s estimated useful life. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred in “Selling, General, and Administrative” in the Consolidated Statements of Operations. See Note 5, “Business Combinations,” for additional information.

(r) Goodwill and Indefinite-Lived Intangibles

 

Goodwill is an asset representing the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. Goodwill is measured as the excess of the consideration transferred over the net of the acquisition-date amounts of the identifiable assets acquired and liabilities assumed. Intangible assets with indefinite useful lives are measured at their respective fair values as of the acquisition date. Intangible assets related to IPR&D projects are considered to be indefinite-lived until the completion or abandonment of the associated R&D efforts. If and when development is complete, the associated assets would be deemed finite-lived and would then be amortized based on their respective estimated useful lives at that point in time. Goodwill and indefinite-lived intangibles are not amortized into results of operations but instead are evaluated for impairment. The Company performs the evaluation in the fourth quarter of each fiscal year or more frequently if impairment indicators arise.

 

The Company first performs a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount, and, if so, the Company then applies the two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting units to their carrying amount. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired, and the Company is not required to perform further testing. If the carrying amount of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and, if the carrying amount of the reporting unit’s goodwill exceeds its implied fair value, then the Company records an impairment loss equal to the difference.

 

The Company determines the fair value of its reporting units based on income and/or market approaches. Determining the fair value of a reporting unit involves the use of significant estimates and assumptions. These estimates and assumptions include revenues and expenses, working capital requirements, residual growth rates, discount rates, and future economic and market conditions. The Company considers historical data, current internal estimates, and market growth trends when developing financial projections. Market participant assumption estimates consider the information being used internally for business planning purposes, however, actual future results may differ from those estimates. Changes in judgments on any of these factors could materially affect the estimated value of the reporting unit.

(s) Long-Lived Assets and Cost Method Investment

 

Definite-lived intangible assets consist of purchased technology, customer-related intangible assets, patents, trademarks, covenants not-to-compete, and software licenses, and are initially recorded at fair value. Definite-lived intangibles are amortized over their estimated useful lives for periods up to 17 years, in a method reflecting the pattern in which the economic benefits are consumed, or straight-lined if such pattern cannot be reliably determined.

 

Property, plant and equipment are recorded at cost. Depreciation expense is calculated based on the estimated useful lives of the assets by using the straight-line method. Amortization of leasehold improvements is recognized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

 

Long-lived assets and cost method investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, a recoverability test is performed utilizing undiscounted cash flows expected to be generated by that asset or asset group compared to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models or, when available, quoted market values and third-party appraisals.

(t) Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU No. 2014-09: Revenue from Contracts with Customers. The amendments in this ASU require that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard outlines a five-step model to be used to make the revenue recognition determination and requires new financial statement disclosures. The standard is effective for interim and annual periods beginning after December 15, 2016 and allows entities to choose among different transition alternatives. The Company is evaluating the impact of adopting the standard on its consolidated financial statements and related financial statement disclosures, and has not yet determined which method of adoption will be selected.

 

The Company has evaluated other pronouncements recently issued but not yet adopted and does not believe the adoption of these pronouncements will have a material impact on the consolidated financial statements.

Income (Loss) Per Common Share (Tables)
Schedule of basic and diluted net income (loss) per common share and the weighted average shares

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands, except per share amounts)

 

Net income (loss)

 

$

(66,940

)

$

(42,263

)

$

30,928

 

Net income (loss) per common share:

 

 

 

 

 

 

 

Basic

 

$

(1.70

)

$

(1.09

)

$

0.80

 

Diluted

 

$

(1.70

)

$

(1.09

)

$

0.79

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

39,350

 

38,807

 

38,477

 

Effect of potentially dilutive share-based awards

 

 

 

574

 

Diluted weighted average shares outstanding

 

39,350

 

38,807

 

39,051

 

 

Fair Value Measurements (Tables)

 

 

December 31, 2014

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(in thousands)

 

U.S. treasuries

 

  $

81,527 

 

  $

 

  $

 

  $

81,527 

 

Corporate debt

 

 

39,045 

 

 

39,045 

 

Assets held for sale

 

 

6,000 

 

 

6,000 

 

 

 

 

December 31, 2013

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(in thousands)

 

U.S. treasuries

 

  $

130,977

 

  $

 

  $

 

  $

130,977

 

Corporate debt

 

 

77,601

 

 

77,601

 

Government agency securities

 

 

61,013

 

 

61,013

 

Commercial paper

 

 

11,947

 

 

11,947

 

Derivative instrument

 

 

907

 

 

907

 

Contingent consideration

 

 

 

(29,368

)

(29,368

)

 

 

 

Contingent

 

 

 

Consideration

 

 

 

(in thousands)

 

Balance as of December 31, 2013

 

$

(29,368

)

Fair value adjustment

 

29,368

 

Balance as of December 31, 2014

 

$

 

 

Invesments (Tables)

 

 

 

 

 

 

Gross

 

 

Gross

 

 

Estimated

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

 

 

 

(in thousands)

 

December 31, 2014

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

81,506

 

$

27

 

$

(6

)

$

81,527

 

Corporate debt

 

39,031

 

20

 

(6

)

39,045

 

Total available-for-sale securities

 

$

120,537

 

$

47

 

$

(12

)

$

120,572

 

 

 

 

 

 

 

 

 

 

 

December 31, 2013

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

130,956

 

$

22

 

$

(1

)

$

130,977

 

Government agency securities

 

61,004

 

9

 

 

61,013

 

Corporate debt

 

77,582

 

55

 

(36

)

77,601

 

Commercial paper

 

11,947

 

 

 

11,947

 

Total available-for-sale securities

 

$

281,489

 

$

86

 

$

(37

)

$

281,538

 

 

 

 

 

December 31, 2014

 

 

December 31, 2013

 

 

 

 

Estimated

 

 

Gross

 

 

Estimated

 

 

Gross

 

 

 

 

Fair

 

 

Unrealized

 

 

Fair

 

 

Unrealized

 

 

 

 

Value

 

 

Losses

 

 

Value

 

 

Losses

 

 

 

(in thousands)

 

U.S. treasuries

 

$

35,001

 

$

(6

)

$

29,068

 

$

(1

)

Corporate debt

 

13,069

 

(6

)

37,654

 

(36

)

Total

 

$

48,070

 

$

(12

)

$

66,722

 

$

(37

)

 

 

 

 

December 31, 2014

 

 

 

 

 

 

 

Estimated

 

 

 

 

Amortized

 

 

Fair

 

 

 

 

Cost

 

 

Value

 

 

 

 

(in thousands)

 

Due in one year or less

 

$

74,710 

 

$

74,718 

 

Due after one year through two years

 

45,827 

 

45,854 

 

Total

 

$

120,537 

 

$

120,572 

 

 

Business Combinations (Tables)

 

 

Acquisition Date

 

 

 

(December 4, 2014)

 

 

 

(in thousands)

 

Amount paid, net of cash acquired

 

$

145,382 

 

Working capital adjustment

 

88 

 

Acquisition date fair value

 

$

145,470 

 

 

 

 

Acquisition Date

 

 

 

(December 4, 2014)

 

 

 

(in thousands)

 

Accounts receivable

 

$

9,383 

 

Inventory

 

13,812 

 

Other current assets

 

463 

 

Property, plant, and equipment

 

6,912 

 

Intangible assets

 

79,810 

 

Total identifiable assets acquired

 

110,380 

 

 

 

 

 

Accounts payable and accrued expenses

 

6,473 

 

Customer deposits

 

6,039 

 

Deferred tax liability, net

 

2,705 

 

Other

 

1,089 

 

Total liabilities assumed

 

16,306 

 

 

 

 

 

Net identifiable assets acquired

 

94,074 

 

Goodwill

 

51,396 

 

Net assets acquired

 

$

145,470 

 

 

 

 

Acquisition Date

 

 

 

(December 4, 2014)

 

 

 

Amount

 

Useful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

39,950 

 

 

10 years

 

Customer relationships

 

34,310 

 

 

14 years

 

Backlog

 

3,340 

 

 

6 months

 

Non-compete agreements

 

1,130 

 

 

2 years

 

Trademark and tradenames

 

1,080 

 

 

1 year

 

Intangible assets acquired

 

$

79,810 

 

 

 

 

 

The amounts of revenue and income (loss) from continuing operations before income taxes of PSP included in the Company’s consolidated statement of operations from the acquisition date (December 4, 2014) to the period ending December 31, 2014 are as follows:

 

 

 

Total

 

 

 

(in thousands)

 

Revenue

 

$

7,906

 

Loss from operations before income taxes

 

$

(3,011

)

 

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Revenue

 

$

447,089

 

$

379,272

 

Loss from operations before income taxes

 

$

(68,715

)

$

(77,252

)

 

 

 

Acquisition Date

 

 

 

(October 1, 2013)

 

 

 

(in thousands)

 

Cash (net of cash acquired)

 

$

71,488

 

Contingent consideration

 

33,539

 

Working capital adjustment

 

(2,695

)

Acquisition date fair value

 

$

102,332

 

 

 

 

Acquisition Date

 

 

 

(October 1, 2013)

 

 

 

(in thousands)

 

Accounts receivable

 

$

1,523 

 

Inventory

 

386 

 

Other current assets

 

512 

 

Property, plant, and equipment

 

1,917 

 

Intangible assets

 

99,270 

 

Total identifiable assets acquired

 

103,608 

 

 

 

 

 

Current liabilities

 

4,370 

 

Estimated deferred tax liability, net

 

32,426 

 

Total liabilities assumed

 

36,796 

 

 

 

 

 

Net identifiable assets acquired

 

66,812 

 

Goodwill

 

35,520 

 

Net assets acquired

 

$

102,332 

 

 

 

 

Acquisition Date

 

 

 

(October 1, 2013)

 

 

 

Amount

 

Uuseful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

73,160 

 

14 years

 

Customer relationships

 

20,630 

 

8 years

 

In-process research and development

 

5,070 

 

To be determined

Trademarks and trade names

 

140 

 

1 year

 

Non-compete agreement

 

270 

 

3 years

 

Intangible assets acquired

 

$

99,270 

 

 

 

 

 

 

December 31,

 

 

 

2013

 

2012

 

 

 

(in thousands)

 

Revenue

 

  $

346,319 

 

  $

522,029 

 

Income (loss) from operations before income taxes

 

  $

(60,983)

 

  $

16,840 

 

 

Goodwill and Intangible Assets (Tables)

 

 

Gross

 

 

 

 

 

 

 

Carrying

 

Accumulated

 

Net

 

 

 

Amount

 

Impairment

 

Amount

 

 

 

(in thousands)

 

As of December 31, 2012

 

$

151,069

 

$

95,241

 

$

55,828

 

Acquisition

 

35,520

 

 

35,520

 

As of December 31, 2013

 

186,589

 

95,241

 

91,348

 

Acquisition

 

51,396

 

 

51,396

 

Purchase price adjustments

 

173

 

 

173

 

Impairments

 

 

27,958

 

(27,958

)

As of December 31, 2014

 

$

238,158

 

$

123,199

 

$

114,959

 

 

 

 

 

 

December 31, 2014

 

December 31, 2013

 

 

 

Weighted

 

 

 

Accumulated

 

 

 

 

 

Accumulated

 

 

 

 

 

Average Remaining

 

Gross

 

Amortization 

 

 

 

Gross

 

Amortization

 

 

 

 

 

Amortization

 

Carrying

 

and

 

Net

 

Carrying

 

and

 

Net

 

 

 

Period

 

Amount

 

Impairment

 

Amount

 

Amount

 

Impairment

 

Amount

 

 

 

(in years)

 

(in thousands)

 

Technology

 

9.6

 

$

222,358 

 

$

106,342 

 

$

116,016 

 

$

182,408 

 

$

97,524 

 

$

84,884 

 

Customer relationships

 

13.9

 

69,350 

 

35,549 

 

33,801 

 

35,040 

 

14,721 

 

20,319 

 

Trademarks and tradenames

 

3.5

 

3,050 

 

1,096 

 

1,954 

 

1,970 

 

763 

 

1,207 

 

Indefinite-lived trademark

 

 

2,900 

 

 

2,900 

 

2,900 

 

 

2,900 

 

IPR&D

 

 

5,070 

 

5,070 

 

 

5,070 

 

 

5,070 

 

Other

 

1.1

 

5,485 

 

848 

 

4,637 

 

765 

 

429 

 

336 

 

Total

 

10.2

 

$

308,213 

 

$

148,905 

 

$

159,308 

 

$

228,153 

 

$

113,437 

 

$

114,716 

 

 

 

 

 

Amortization

 

 

 

 

(in thousands)

 

2015

 

 

$

27,003 

 

2016

 

 

20,969 

 

2017

 

 

18,100 

 

2018

 

 

16,492 

 

2019

 

 

15,235 

 

Thereafter

 

 

58,609 

 

Total

 

 

$

156,408 

 

 

Inventories (Tables)
Schedule of inventories

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Materials

 

$

30,319 

 

$

34,301 

 

Work-in-process

 

25,096 

 

12,900 

 

Finished goods

 

6,056 

 

12,525 

 

Total

 

$

61,471 

 

$

59,726 

 

 

Property, Plant, and Equipment (Tables)
Schedule of property, plant and equipment

 

 

 

December 31,

 

 

Average

 

 

 

 

2014

 

2013

 

 

Useful Life

 

 

 

(in thousands)

 

 

 

 

Land

 

$

9,392 

 

$

12,535 

 

 

 

Building and improvements

 

51,979 

 

52,050 

 

10 – 40 years

 

Machinery and equipment

 

104,815 

 

110,228 

 

3 – 10 years

 

Leasehold improvements

 

4,356 

 

5,888 

 

3 – 7 years

 

Gross property,plant and equipment

 

170,542 

 

180,701 

 

 

 

Less: accumulated depreciation and amortization

 

91,790 

 

91,562 

 

 

 

Net property, plant, and equipment

 

$

78,752 

 

$

89,139 

 

 

 

 

Accrued Expenses and Other Liabilities (Tables)
Schedule of accrued expenses and other current liabilities

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Payroll and related benefits

 

$

26,605 

 

$

11,020 

 

Sales, use, and other taxes

 

1,776 

 

5,402 

 

Contingent consideration

 

 

20,098 

 

Warranty

 

5,411 

 

5,662 

 

Restructuring liability

 

1,428 

 

533 

 

Other

 

13,198 

 

8,369 

 

Total

 

$

48,418 

 

$

51,084 

 

 

Discontinued Operations (Tables)
Summary of information related to discontinued operations

 

 

 

2012

 

 

 

Solar

 

 

 

 

 

 

 

 

 

 

Systems

 

 

Metrology

 

 

Total

 

 

 

(in thousands)

 

Net sales

 

$

 

 

$

 

 

$

 

Net income (loss) from discontinued operations

 

$

(62

)

 

$

4,461

 

 

$

4,399

 

 

Restructuring Charges (Tables)
Schedule of restructuring activity

 

 

Personnel

 

 

 

 

 

 

 

 

 

Severance and

 

 

Facility

 

 

 

 

 

 

 

Related Costs

 

 

Closing Costs

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2012

 

$

1,875

 

 

$

 

 

$

1,875

 

Provision

 

1,485

 

 

 

 

1,485

 

Payments

 

(2,827

)

 

 

 

(2,827

)

Balance at December 31, 2013

 

533

 

 

 

 

533

 

Provision

 

4,012

 

 

382

 

 

4,394

 

Payments

 

(3,117

)

 

(382

)

 

(3,499

)

Balance at December 31, 2014

 

$

1,428

 

 

$

 

 

$

1,428

 

 

Commitments and Contingencies (Tables)

 

 

 

December 31,

 

 

 

 

2014

 

 

2013

 

 

 

(in thousands)

 

Balance, beginning of the year

 

$

5,662

 

 

$

4,942

 

Addition for new warranties issued

 

3,484

 

 

5,291

 

Addition from PSP acquisition

 

809

 

 

 

Settlements

 

(3,802

)

 

(5,580

)

Changes in estimate

 

(742

)

 

1,009

 

Balance, end of the year

 

$

5,411

 

 

$

5,662

 

 

Minimum lease commitments at December 31, 2014 for property and equipment under operating lease agreements (exclusive of renewal options) are payable as follows:

 

 

 

Operating

 

 

 

 

Leases

 

Payments due by period:

 

 

(in thousands)

 

2015

 

$

2,322 

 

2016

 

2,423 

 

2017

 

1,993 

 

2018

 

1,224 

 

2019

 

526 

 

Thereafter

 

2,700 

 

Total

 

$

11,188 

 

 

 

 

Accounts Receivable

 

Net Sales for the Year Ended

 

 

 

Year ended December 31,

 

December 31,

 

Customer

 

2014

 

2013

 

2014

 

2013

 

2012

 

Customer A

 

 

*

 

 

*

 

 

15%

 

 

*

 

 

*

 

Customer B

 

 

20%

 

 

10%

 

 

11%

 

 

14%

 

 

*

 

Customer C

 

 

13%

 

 

11%

 

 

*

 

 

*

 

 

*

 

Customer D

 

 

*

 

 

23%

 

 

*

 

 

*

 

 

14%

 

 

* Less than 10% of aggregate accounts receivable or net sales.

 

 

 

December 31,

 

 

 

 

2014

 

 

2013

 

 

 

(in thousands)

 

China

 

$

17,911 

 

 

$

4,130 

 

Korea

 

8,118 

 

 

2,411 

 

Thailand

 

6,324 

 

 

2,041 

 

Taiwan

 

5,838 

 

 

427 

 

Other

 

3,986 

 

 

4,890 

 

Asia Pacific

 

42,177 

 

 

13,899 

 

United States

 

13,139 

 

 

8,369 

 

EMEA and other

 

4,769 

 

 

1,555 

 

Total

 

$

60,085 

 

 

$

23,823 

 

 

Debt (Tables)
Schedule of maturity of long-term debt

 

 

 

Total

 

 

 

(in thousands)

 

2015

 

$

314 

 

2016

 

340 

 

2017

 

368 

 

2018

 

398 

 

2019

 

427 

 

Total

 

1,847 

 

Less current portion

 

314 

 

Total (less current maturities)

 

$

1,533 

 

 

Derivative Financial Instruments (Tables)

 

 

Fair

 

Maturity

 

Notional

 

 

 

 

Value

 

Dates

 

Amount

 

 

 

(in thousands)

 

December 31, 2013

 

 

 

 

 

 

 

Foreign currency exchange forwards

 

$

 

January 2014

 

$

4,700 

 

Foreign currency collar

 

906 

 

October 2014

 

34,069 

 

Total

 

$

907 

 

 

 

$

38,769 

 

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

Foreign currency exchange forwards

 

$

(89

)

$

248

 

$

333

 

Foreign currency collar

 

(457

)

906

 

 

 

 

$

(546

)

$

1,154

 

$

333

 

 

Stockholders Equity (Tables)
Schedule of the components of accumulated other comprehensive income

 

 

 

Foreign

 

 

Minimum

 

 

Unrealized

 

 

 

 

 

 

 

Currency

 

 

Pension

 

 

Gains (losses) on

 

 

 

 

 

 

 

Translation

 

 

Liability

 

 

AFS Securities

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2012

 

$

6,701

 

$

(775

)

$

47

 

$

5,973

 

Other comprehensive income (loss) before reclassifications

 

(1,322

)

125

 

34

 

(1,163

)

Benefit (provision) for income taxes

 

(53

)

(86

)

11

 

(128

)

Amounts reclassified from AOCI

 

 

 

(61

)

(61

)

Other comprehensive income (loss)

 

(1,375

)

39

 

(16

)

(1,352

)

Balance at December 31, 2013

 

5,326

 

(736

)

31

 

4,621

 

Other comprehensive income (loss) before reclassifications

 

149

 

(145

)

51

 

55

 

Amounts reclassified from AOCI

 

(3,142

)

 

(65

)

(3,207

)

Other comprehensive income (loss)

 

(2,993

)

(145

)

(14

)

(3,152

)

Balance at December 31, 2014

 

$

2,333

 

$

(881

)

$

17

 

$

1,469

 

 

Stock Plans (Tables)

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

 

 

(in thousands)

 

 

 

Cost of sales

 

$

2,456

 

$

1,446

 

$

1,467

 

Selling, general, and administrative

 

11,859

 

8,339

 

9,677

 

Research and development

 

4,498

 

3,347

 

2,709

 

Share-based compensation expense before tax

 

18,813

 

13,132

 

13,853

 

Income tax benefit

 

(6,011

)

(4,367

)

(4,849

)

Net share-based compensation expense

 

$

12,802

 

$

8,765

 

$

9,004

 

 

The following table summarizes information about unrecognized share-based compensation costs at December 31, 2014:

 

 

 

Unrecognized

 

Weighted

 

 

 

Share-Based

 

Average Period

 

 

 

Compensation

 

Expected to be

 

 

 

Costs

 

Recognized

 

 

 

(in thousands)

 

(in years)

 

Stock option awards

 

$

9,939 

 

2.0 

 

Restricted stock units

 

9,980 

 

2.5 

 

Restricted stock awards

 

17,501 

 

2.8 

 

Performance share units

 

2,855 

 

3.3 

 

Performance share awards

 

152 

 

0.4 

 

Total unrecognized share-based compensation cost

 

$

40,427 

 

2.5 

 

 

Stock options are awards issued to employees that entitle the holder to purchase shares of the Company’s stock at a fixed price. At December 31, 2014, options outstanding that have vested and are expected to vest were as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Number

 

Weighted

 

Average

 

Aggregate

 

 

 

of

 

Average

 

Remaining

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Contractual Life

 

Value

 

 

 

(in thousands)

 

 

 

(in years)

 

(in thousands)

 

Vested

 

1,409 

 

$

30.76 

 

5.2 

 

$

10,127 

 

Expected to vest

 

903 

 

$

32.93 

 

7.7 

 

2,091 

 

Total

 

2,312 

 

$

31.61 

 

6.2 

 

$

12,218 

 

 

 

 

 

 

Weighted

 

 

 

Number of

 

Average

 

 

 

Shares

 

Exercise Price

 

 

 

(in thousands)

 

 

 

Outstanding at December 31, 2011

 

2,106

 

$

25.58

 

Granted

 

704

 

32.55

 

Exercised

 

(351

)

15.39

 

Expired or forfeited

 

(137

)

35.88

 

Outstanding at December 31, 2012

 

2,322

 

$

28.63

 

Granted

 

539

 

32.68

 

Exercised

 

(149

)

14.74

 

Expired or forfeited

 

(114

)

35.22

 

Outstanding at December 31, 2013

 

2,598

 

$

29.98

 

Granted

 

509

 

33.05

 

Exercised

 

(561

)

23.88

 

Expired or forfeited

 

(155

)

36.22

 

Outstanding at December 31, 2014

 

2,391

 

$

31.65

 

 

The following table summarizes stock option information at December 31, 2014:

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Aggregate

 

Average

 

Weighted

 

 

 

Aggregate

 

Average

 

Weighted

 

Range of

 

 

 

Intrinsic

 

Remaining

 

Average

 

 

 

Intrinsic

 

Remaining

 

Average

 

Exercise Prices

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

Shares

 

Value

 

Contractual Life

 

Exercise Price

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

(in thousands)

 

(in thousands)

 

(in years)

 

 

 

$8.82 – $17.48

 

386 

 

$

8,769 

 

1.3 

 

$

12.15 

 

386 

 

$

8,769 

 

1.3 

 

$

12.15 

 

$20.80 – $31.45

 

347 

 

1,626 

 

8.8 

 

30.20 

 

125 

 

616 

 

8.7 

 

29.94 

 

$31.91 – $48.04

 

1,429 

 

2,000 

 

6.9 

 

34.14 

 

669 

 

742 

 

6.4 

 

34.63 

 

$48.90 – $51.70

 

229 

 

 

6.4 

 

51.21 

 

229 

 

 

6.4 

 

51.21 

 

 

 

2,391 

 

$

12,395 

 

6.2 

 

$

31.65 

 

1,409 

 

$

10,127 

 

5.2 

 

$

30.76 

 

 

 

 

Year ended December 31,

 

 

2014

 

2013

 

2012

Weighted average fair value

 

$

11.58 

 

$

13.47 

 

$

15.56 

Dividend yield

 

%

 

%

 

%

Expected volatility factor(1)

 

44 

%

 

49 

%

 

59 

%

Risk-free interest rate(2)

 

1.19 

%

 

1.27 

%

 

0.70 

%

Expected life(in years)(3)

 

3.9 

 

4.5 

 

4.5 

 

(1)

Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term of the options and the implied volatility derived from the market prices of the Company’s traded opt ions.

 

(2)

The risk-free rate for periods within the contractual term of the stock options is based on the U.S. Treasury yield curve in effect at the time of grant.

 

(3)

The expected life is the number of years the Company estimates that options will be out standing prior to exercise. The Company’s computation of expected life was determined using a lattice-based model incorporating historical post vest exercise and employee termination behavior.

 

 

Year ended December 31,

 

 

2014

 

2013

 

2012

 

 

 

 

(in thousands)

 

 

Cash received from options exercised

 

$

12,056 

 

$

2,199 

 

$

5,409 

Intrinsic value of options exercised

 

$

8,390 

 

$

2,509 

 

$

6,800 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

Number of

 

Grant Date

 

 

 

Shares

 

Fair Value

 

 

 

(in thousands)

 

 

 

Outstanding at December 31, 2011

 

618

 

$

33.61

 

Granted

 

324

 

32.62

 

Released

 

(167

)

20.60

 

Forfeitures

 

(82

)

34.98

 

Outstanding at December 31, 2012

 

693

 

$

36.11

 

Granted

 

798

 

33.16

 

Released

 

(207

)

32.44

 

Forfeitures

 

(126

)

34.33

 

Outstanding at December 31, 2013

 

1,158

 

$

34.93

 

Granted

 

395

 

34.18

 

Released

 

(183

)

38.65

 

Forfeitures

 

(133

)

33.66

 

Outstanding at December 31, 2014

 

1,237

 

$

34.27

 

 

Income Taxes (Tables)

 

 

Year ended December 31,

 

 

 

2014

 

 

2013

 

 

2012

 

 

 

 

 

 

(in thousands)

 

 

 

 

Domestic

 

$

(95,195

)

 

$

(84,942

)

 

$

5,811

 

Foreign

 

16,841

 

 

13,732

 

 

32,375

 

 

 

$

(78,354

)

 

$

(71,210

)

 

$

38,186

 

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

 

 

(in thousands)

 

 

 

Current:

 

 

 

 

 

 

 

Federal

 

$

(2,464

)

$

(21,022

)

$

2,515

 

Foreign

 

2,325

 

3,921

 

7,576

 

State and local

 

55

 

148

 

(317

)

Total current provision (benefit) for income taxes

 

(84

)

(16,953

)

9,774

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(11,230

)

(11,589

)

(482

)

Foreign

 

(291

)

(462

)

727

 

State and local

 

191

 

57

 

1,638

 

Total deferred provision (benefit) for income taxes

 

(11,330

)

(11,994

)

1,883

 

Total provision (benefit) for income taxes

 

$

(11,414

)

$

(28,947

)

$

11,657

 

 

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

 

 

(in thousands)

 

 

 

Income tax provision (benefit) at U.S. statutory rates

 

$

(27,424

)

$

(24,923

)

$

13,366

 

State taxes, net of U.S. federal impact

 

(662

)

(1,554

)

(89

)

Effect of international operations

 

(6,160

)

(4,275

)

(2,387

)

Domestic production activities deduction

 

 

1,554

 

(489

)

Research and development tax credit

 

(1,935

)

(3,151

)

(3,013

)

Net change in valuation allowance

 

27,156

 

2,420

 

2,943

 

Change in accrual for unrecognized tax benefits

 

(1,940

)

577

 

533

 

Goodwill impairment

 

9,786

 

 

 

Change in contingent consideration

 

(10,279

)

290

 

 

Other

 

44

 

115

 

793

 

Total provision (benefit) for income taxes

 

$

(11,414

)

$

(28,947

)

 $

11,657

 

 

 

 

December 31,

 

 

 

2014

 

2013

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

Inventory valuation

 

$

8,244

 

$

6,983

 

Net operating losses and credit carry forwards

 

39,750

 

18,972

 

Warranty and installation accruals

 

2,452

 

3,002

 

Share-based compensation

 

11,794

 

10,638

 

Other

 

2,647

 

3,716

 

Total deferred tax assets

 

64,887

 

43,311

 

Valuation allowance

 

(34,909

)

(7,753

)

Net deferred tax assets

 

29,978

 

35,558

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Purchased intangible assets

 

34,018

 

45,208

 

Undistributed earnings

 

1,047

 

1,737

 

Depreciation

 

2,274

 

4,711

 

Total deferred tax liabilities

 

37,339

 

51,656

 

Net deferred taxes

 

$

(7,361

)

$

(16,098

)

 

 

 

December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

Balance at beginning of year

 

$

6,228

 

$

5,818

 

$

4,748

 

Additions for tax positions related to current year

 

244

 

324

 

435

 

Additions for tax positions related to prior years

 

199

 

477

 

742

 

Reductions for tax positions related to prior years

 

(2,345

)

(224

)

(59

)

Reductions due to the lapse of the applicable statute of limitations

 

(38

)

 

(48

)

Settlements

 

(12

)

(167

)

 

Balance at end of year

 

$

4,276

 

$

6,228

 

$

5,818

 

 

Segment Reporting and Geographic Information (Tables)

 

 

Year ended December 31,

 

 

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

MOCVD

 

$

279,751 

 

$

219,914 

 

$

314,152 

 

MBE

 

28,033 

 

29,419 

 

49,029 

 

Surface Processing

 

7,906 

 

 

 

Ion Beam and other

 

77,183 

 

82,416 

 

152,839 

 

Total Revenue

 

$

392,873 

 

$

331,749 

 

$

516,020 

 

 

 

 

 

Net Sales to Unaffiliated Customers

 

Long-Lived Tangible Assets

 

 

 

2014

 

2013

 

2012

 

2014

 

2013

 

2012

 

 

 

(in thousands)

 

United States

 

$

44,060 

 

$

57,609 

 

$

83,317 

 

$

63,349 

 

$

66,002 

 

$

74,497 

 

Asia Pacific(1)

 

311,182 

 

252,199 

 

390,995 

 

15,325 

 

23,042 

 

23,769 

 

EMEA(2) and other

 

37,631 

 

21,941 

 

41,708 

 

78 

 

95 

 

36 

 

Total

 

$

392,873 

 

$

331,749 

 

$

516,020 

 

$

78,752 

 

$

89,139 

 

$

98,302 

 

 

(1)

Net sales to customers in China were 40%, 45%, and 42% of total net sales for the years ended December 31, 2014, 2013, 2012, respectively.

 

(2)

Consists of Europe, the Middle East, and Africa

Selected Quarterly Financial Information (Tables)
Schedule of unaudited quarterly results

 

 

Fiscal 2014

 

Fiscal 2013

 

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Q1

 

Q2

 

Q3

 

Q4

 

 

 

(in thousands, except per share amounts)

Net sales

 

$

90,841 

 

$

95,122 

 

$

93,341 

 

$

113,569 

 

$

61,781 

 

$

97,435 

 

$

99,324 

 

$

73,209 

 

Gross profit

 

$

33,777 

 

$

30,673 

 

$

 

32,558 

 

$

37,874 

 

$

22,552 

 

$

34,640 

 

$

30,308 

 

$

15,642 

 

Net income (loss)

 

$

19,160 

 

$

(15,211)

 

$

 

(13,977)

 

$

(56,912)

 

$

(10,071)

 

$

(4,081)

 

$

(6,026)

 

$

(22,085)

 

Basic income (loss) per common share

 

$

0.49 

 

$

(0.39)

 

$

 

(0.35)

 

$

(1.44)

 

$

(0.26)

 

$

(0.11)

 

$

(0.16)

 

$

(0.57)

 

Diluted income (loss) per common share

 

$

0.48 

 

$

(0.39)

 

$

 

(0.35)

 

$

(1.44)

 

$

(0.26)

 

$

(0.11)

 

$

(0.16)

 

$

(0.57)

 

 

Significant Accounting Policies (Details)
12 Months Ended
Dec. 31, 2014
Significant Accounting Policies
 
Number of Weeks in Fiscal Quarter 52 Week Year
91 days 
Revenue Recognition
 
Revenue retention percentage
10.00% 
Significant Accounting Policies (Details 2) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Warranty Costs
 
 
 
Warranty period
1 year 
 
 
Advertising Expense
 
 
 
Advertising expenses
$ 0.6 
$ 0.5 
$ 0.8 
Concentration of Credit Risk
 
 
 
Allowance for doubtful accounts
$ 0.7 
$ 2.4 
 
Maturity period of irrevocable letters of credit, minimum
0 days 
 
 
Maturity period of irrevocable letters of credit, maximum
90 days 
 
 
Cash, Cash Equivalents, and Short-Term Investments
 
 
 
Maturity period of short-term investments, minimum
3 months 
 
 
Cash and cash equivalents maintained outside the U.S. by subsidiaries (as a percent)
81.00% 
71.00% 
 
Maximum
 
 
 
Long-Lived Intangible Assets
 
 
 
Estimated useful lives
17 years 
 
 
Income (Loss) Per Common Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income (Loss) Per Common Share
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$ (56,912)
$ (13,977)
$ (15,211)
$ 19,160 
$ (22,085)
$ (6,026)
$ (4,081)
$ (10,071)
$ (66,940)
$ (42,263)
$ 30,928 
Net income (loss) per common share:
 
 
 
 
 
 
 
 
 
 
 
Basic (in dollars per share)
$ (1.44)
$ (0.35)
$ (0.39)
$ 0.49 
$ (0.57)
$ (0.16)
$ (0.11)
$ (0.26)
$ (1.70)
$ (1.09)
$ 0.80 
Diluted (in dollars per share)
$ (1.44)
$ (0.35)
$ (0.39)
$ 0.48 
$ (0.57)
$ (0.16)
$ (0.11)
$ (0.26)
$ (1.70)
$ (1.09)
$ 0.79 
Basic weighted average shares outstanding
 
 
 
 
 
 
 
 
39,350 
38,807 
38,477 
Effect of potentially dilutive share-based awards
 
 
 
 
 
 
 
 
 
 
574 
Diluted weighted average shares outstanding
 
 
 
 
 
 
 
 
39,350 
38,807 
39,051 
Income (Loss) Per Common Share (Details 2)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income Per Common Share
 
 
 
Securities excluded from the calculation of diluted net income (loss) per share (in shares)
0.7 
0.6 
 
Stock options and Restricted stock
 
 
 
Income Per Common Share
 
 
 
Securities excluded from the calculation of diluted net income (loss) per share (in shares)
1.6 
1.3 
1.3 
Fair Value Measurements (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Assets held for sale
$ 6,000 
 
Assets and liabilities measured on a recurring basis |
Level 1 |
U.S. treasuries
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
81,527 
130,977 
Assets and liabilities measured on a recurring basis |
Level 2
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Assets held for sale
6,000 
 
Derivative instrument
 
907 
Assets and liabilities measured on a recurring basis |
Level 2 |
Corporate debt
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
39,045 
77,601 
Assets and liabilities measured on a recurring basis |
Level 2 |
Government agency securities
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
 
61,013 
Assets and liabilities measured on a recurring basis |
Level 2 |
Commercial paper
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
 
11,947 
Assets and liabilities measured on a recurring basis |
Level 3
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Contingent consideration
 
(29,368)
Assets and liabilities measured on a recurring basis |
Total
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Assets held for sale
6,000 
 
Derivative instrument
 
907 
Contingent consideration
 
(29,368)
Assets and liabilities measured on a recurring basis |
Total |
U.S. treasuries
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
81,527 
130,977 
Assets and liabilities measured on a recurring basis |
Total |
Corporate debt
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
39,045 
77,601 
Assets and liabilities measured on a recurring basis |
Total |
Government agency securities
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
 
61,013 
Assets and liabilities measured on a recurring basis |
Total |
Commercial paper
 
 
Major categories of assets and liabilities measured on a recurring basis, at fair value
 
 
Cash equivalents and short-term investments
 
$ 11,947 
Fair Value Measurements (Details 2) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Other current liabilities
Dec. 31, 2013
Other noncurrent liabilities
Dec. 31, 2014
Level 3
Reconciliation of the amount in Level 3
 
 
 
Balance at the beginning of the period
 
 
$ (29,368)
Fair value adjustment of contingent consideration
 
 
29,368 
Measurement of certain assets for fair value on a non-recurring basis
 
 
 
Contingent consideration
$ 20,100 
$ 9,300 
 
Investments (Details) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Total available-for-sale securities
 
 
 
Amortized Cost
$ 120,537,000 
$ 281,489,000 
 
Gross Unrealized Gains
47,000 
86,000 
 
Gross Unrealized Losses
(12,000)
(37,000)
 
Estimated Fair Value
120,572,000 
281,538,000 
 
Available-for-sale securities in a loss position
 
 
 
Estimated Fair value
48,070,000 
66,722,000 
 
Gross Unrealized Losses
(12,000)
(37,000)
 
Investments that had been in a continuous loss position for more than 12 months
 
Amortized costs of contractual maturities of available-for-sale securities
 
 
 
Due in one year or less
74,710,000 
 
 
Due after one year through two years
45,827,000 
 
 
Gross realized gains on available-for-sale securities
100,000 
100,000 
 
Gross realized losses on available-for-sale securities
Estimated fair value of contractual maturities of available-for-sale securities
 
 
 
Due in one year or less
74,718,000 
 
 
Due after one year through two years
45,854,000 
 
 
Total available-for-sale securities
120,572,000 
281,538,000 
 
U.S. treasuries
 
 
 
Total available-for-sale securities
 
 
 
Amortized Cost
81,506,000 
130,956,000 
 
Gross Unrealized Gains
27,000 
22,000 
 
Gross Unrealized Losses
(6,000)
(1,000)
 
Estimated Fair Value
81,527,000 
130,977,000 
 
Available-for-sale securities in a loss position
 
 
 
Estimated Fair value
35,001,000 
29,068,000 
 
Gross Unrealized Losses
(6,000)
(1,000)
 
Government agency securities
 
 
 
Total available-for-sale securities
 
 
 
Amortized Cost
 
61,004,000 
 
Gross Unrealized Gains
 
9,000 
 
Estimated Fair Value
 
61,013,000 
 
Corporate debt
 
 
 
Total available-for-sale securities
 
 
 
Amortized Cost
39,031,000 
77,582,000 
 
Gross Unrealized Gains
20,000 
55,000 
 
Gross Unrealized Losses
(6,000)
(36,000)
 
Estimated Fair Value
39,045,000 
77,601,000 
 
Available-for-sale securities in a loss position
 
 
 
Estimated Fair value
13,069,000 
37,654,000 
 
Gross Unrealized Losses
(6,000)
(36,000)
 
Commercial paper
 
 
 
Total available-for-sale securities
 
 
 
Amortized Cost
 
11,947,000 
 
Estimated Fair Value
 
$ 11,947,000 
 
Investments (Details 2) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Investments
 
 
Restricted cash
$ 539 
$ 2,738 
Investments (Details 3) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Cost Method Investment
 
 
Carrying value of the investment
$ 19.4 
$ 16.9 
Maximum
 
 
Cost Method Investment
 
 
Percentage ownership of cost method investee
20.00% 
 
Business Combinations (Details) (USD $)
12 Months Ended 0 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 4, 2014
PSP
Dec. 31, 2014
PSP
Dec. 31, 2014
PSP
Dec. 31, 2013
PSP
Dec. 4, 2014
PSP
Technology
Dec. 4, 2014
PSP
Customer relationship
Dec. 4, 2014
PSP
Backlog
Dec. 4, 2014
PSP
Trademarks and tradenames
Dec. 4, 2014
PSP
Non-compete agreements
Oct. 1, 2013
ALD
Dec. 31, 2014
ALD
Mar. 31, 2014
ALD
Dec. 31, 2014
ALD
Dec. 31, 2013
ALD
Dec. 31, 2012
ALD
Oct. 1, 2013
ALD
Oct. 1, 2013
ALD
Technology
Oct. 1, 2013
ALD
Technology
Oct. 1, 2013
ALD
Customer relationship
Oct. 1, 2013
ALD
Customer relationship
Oct. 1, 2013
ALD
Trademarks and tradenames
Oct. 1, 2013
ALD
Trademarks and tradenames
Oct. 1, 2013
ALD
Non-compete agreements
Oct. 1, 2013
ALD
Non-compete agreements
Oct. 1, 2013
ALD
IPR&D
Business combination
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage of ownership acquired
 
 
 
100.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100.00% 
 
 
 
 
 
 
 
 
 
Decrease in working capital adjustment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 1,400,000 
 
 
 
 
 
 
 
 
 
 
 
 
Increase in goodwill as result of working capital adjustments
173,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
200,000 
 
 
 
 
 
 
 
 
 
 
 
 
Reduction in accrued expenses as a result of working capital adjustment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,200,000 
 
 
 
 
 
 
 
 
 
 
 
 
Working capital adjustment payment received
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,300,000 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value of the consideration transferred
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount paid (net of cash acquired)
 
 
 
145,382,000 
 
 
 
 
 
 
 
 
71,488,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent consideration
 
 
 
 
 
 
 
 
 
 
 
 
33,539,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Working capital adjustment
 
 
 
88,000 
 
 
 
 
 
 
 
 
(2,695,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
145,470,000 
 
 
 
 
 
 
 
 
102,332,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent consideration earned and paid
 
5,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5,000,000 
 
 
 
 
 
 
 
 
 
 
 
Amount of change in contingent consideration as a result of changes in the fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(29,400,000)
(29,400,000)
800,000 
 
 
 
 
 
 
 
 
 
 
 
Summary of estimated fair values of the assets acquired and liabilities assumed
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Account receivable
 
 
 
9,383,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,523,000 
 
 
 
 
 
 
 
 
 
Inventory
 
 
 
13,812,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
386,000 
 
 
 
 
 
 
 
 
 
Other current assets
 
 
 
463,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
512,000 
 
 
 
 
 
 
 
 
 
Property, plant, and equipment
 
 
 
6,912,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,917,000 
 
 
 
 
 
 
 
 
 
Intangible assets
 
 
 
79,810,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99,270,000 
 
 
 
 
 
 
 
 
 
Total identifiable assets acquired
 
 
 
110,380,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103,608,000 
 
 
 
 
 
 
 
 
 
Accounts payable and accrued expenses
 
 
 
6,473,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Customer deposits
 
 
 
6,039,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4,370,000 
 
 
 
 
 
 
 
 
 
Other
 
 
 
1,089,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated deferred tax liability, net
 
 
 
2,705,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32,426,000 
 
 
 
 
 
 
 
 
 
Total liabilities assumed
 
 
 
16,306,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36,796,000 
 
 
 
 
 
 
 
 
 
Net identifiable assets acquired
 
 
 
94,074,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66,812,000 
 
 
 
 
 
 
 
 
 
Goodwill
114,959,000 
91,348,000 
55,828,000 
51,396,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35,520,000 
 
 
 
 
 
 
 
 
 
Net assets acquired
 
 
 
145,470,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
102,332,000 
 
 
 
 
 
 
 
 
 
Gross contractual value of accounts receivable
 
 
 
10,500,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage of goodwill expected to be tax deductible
 
 
 
80.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangible assets acquired and the estimated weighted-average useful life
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finite lived intangible assets acquired, amount
 
 
 
79,810,000 
 
 
 
39,950,000 
34,310,000 
3,340,000 
1,080,000 
1,130,000 
 
 
 
 
 
 
99,270,000 
 
73,160,000 
 
20,630,000 
 
140,000 
 
270,000 
5,070,000 
Intangible assets acquired, amount
 
 
 
79,810,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99,270,000 
 
 
 
 
 
 
 
 
 
Asset impairment
58,170,000 
1,220,000 
1,335,000 
 
 
 
 
 
 
 
 
 
 
53,900,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average useful life
 
 
 
 
 
 
 
10 years 
14 years 
6 months 
1 year 
2 years 
 
 
 
 
 
 
 
14 years 
 
8 years 
 
1 year 
 
3 years 
 
 
Acquisition related costs
 
 
 
 
 
3,200,000 
 
 
 
 
 
 
 
 
 
 
1,000,000 
 
 
 
 
 
 
 
 
 
 
 
Revenue and income (loss) from continuing operations before income taxes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
7,906,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Income (loss)
 
 
 
 
(3,011,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pro forma consolidated statement of operations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
447,089,000 
379,272,000 
 
 
 
 
 
 
 
 
 
346,319,000 
522,029,000 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations before income taxes
 
 
 
 
 
$ (68,715,000)
$ (77,252,000)
 
 
 
 
 
 
 
 
 
$ (60,983,000)
$ 16,840,000 
 
 
 
 
 
 
 
 
 
 
Goodwill and Intangible Assets (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended 3 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2014
Certain tangible assets
Dec. 31, 2014
Goodwill
Dec. 31, 2014
Other long-lived assets
Dec. 31, 2014
Other long-lived assets
Customer relationship
Dec. 31, 2014
Other long-lived assets
IPR&D
Goodwill
 
 
 
 
 
 
 
 
Gross carrying Amount, beginning balance
$ 186,589 
$ 151,069 
 
 
 
 
 
 
Accumulated Impairment, beginning balance
95,241 
95,241 
 
 
 
 
 
 
Net Amount, beginning balance
91,348 
55,828 
 
 
 
 
 
 
Acquisition
51,396 
35,520 
 
 
 
 
 
 
Purchase price adjustment
173 
 
 
 
 
 
 
 
Impairments
27,958 
 
 
 
 
 
 
 
Gross carrying Amount, ending balance
238,158 
186,589 
151,069 
 
 
 
 
 
Accumulated Impairment, ending balance
123,199 
95,241 
95,241 
 
 
 
 
 
Net Amount, ending balance
114,959 
91,348 
55,828 
 
 
 
 
 
Asset impairment
$ 58,170 
$ 1,220 
$ 1,335 
$ 3,600 
$ 28,000 
$ 25,900 
$ 17,400 
$ 4,800 
Goodwill and Intangible Assets (Details 2) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Intangible Assets
 
 
 
Weighted Average Remaining Amortization Period
10 years 2 months 12 days 
 
 
Gross Carrying Amount
$ 308,213 
$ 228,153 
 
Accumulated Amortization and Impairment
148,905 
113,437 
 
Net Amount
159,308 
114,716 
 
Estimated aggregate amortization expense
 
 
 
2015
27,003 
 
 
2016
20,969 
 
 
2017
18,100 
 
 
2018
16,492 
 
 
2019
15,235 
 
 
Thereafter
58,609 
 
 
Net Amount
156,408 
 
 
Amortization expense for other intangible assets
13,146 
5,527 
4,908 
Technology
 
 
 
Intangible Assets
 
 
 
Weighted Average Remaining Amortization Period
9 years 7 months 6 days 
 
 
Gross Carrying Amount
222,358 
182,408 
 
Accumulated Amortization and Impairment
106,342 
97,524 
 
Net Amount
116,016 
84,884 
 
Customer relationship
 
 
 
Intangible Assets
 
 
 
Weighted Average Remaining Amortization Period
13 years 10 months 24 days 
 
 
Gross Carrying Amount
69,350 
35,040 
 
Accumulated Amortization and Impairment
35,549 
14,721 
 
Net Amount
33,801 
20,319 
 
Trademarks and tradenames
 
 
 
Intangible Assets
 
 
 
Weighted Average Remaining Amortization Period
3 years 6 months 
 
 
Gross Carrying Amount
3,050 
1,970 
 
Accumulated Amortization and Impairment
1,096 
763 
 
Net Amount
1,954 
1,207 
 
Indefinite-lived trademark [member]
 
 
 
Intangible Assets
 
 
 
Gross Carrying Amount
2,900 
2,900 
 
Net Amount
2,900 
2,900 
 
IPR&D
 
 
 
Intangible Assets
 
 
 
Gross Carrying Amount
5,070 
5,070 
 
Accumulated Amortization and Impairment
5,070 
 
 
Net Amount
 
5,070 
 
Other Intangible Assets
 
 
 
Intangible Assets
 
 
 
Weighted Average Remaining Amortization Period
1 year 1 month 6 days 
 
 
Gross Carrying Amount
5,485 
765 
 
Accumulated Amortization and Impairment
848 
429 
 
Net Amount
$ 4,637 
$ 336 
 
Inventories (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Inventories
 
 
Materials
$ 30,319 
$ 34,301 
Work in process
25,096 
12,900 
Finished goods
6,056 
12,525 
Inventories
$ 61,471 
$ 59,726 
Property, Plant, and Equipment (Details) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Property, Plant and Equipment
 
 
 
Gross property, plant, and equipment
$ 170,542,000 
$ 180,701,000 
 
Less accumulated depreciation and amortization
91,790,000 
91,562,000 
 
Net property, plant, and equipment
78,752,000 
89,139,000 
 
Depreciation
11,400,000 
12,900,000 
11,300,000 
Assets held for sale
6,000,000 
 
 
Property, plant and equipment, net
 
 
 
Transfers from property, plant and equipment
9,500,000 
 
 
Asset impairment
58,170,000 
1,220,000 
1,335,000 
Assets held for sale
6,000,000 
 
 
Property, Plant and Equipment
 
 
 
Property, plant and equipment, net
 
 
 
Asset impairment
3,500,000 
 
 
Tools
 
 
 
Property, Plant and Equipment
 
 
 
Assets held for sale
1,300,000 
7,200,000 
 
Aggregate sales
8,900,000 
7,400,000 
 
Assets converted and sold
7,400,000 
3,700,000 
 
Property, plant and equipment, net
 
 
 
Asset impairment
100,000 
900,000 
 
Assets held for sale
1,300,000 
7,200,000 
 
Aggregate selling price
8,900,000 
7,400,000 
 
Land
 
 
 
Property, Plant and Equipment
 
 
 
Gross property, plant, and equipment
9,392,000 
12,535,000 
 
Property, plant and equipment, net
 
 
 
Asset impairment
1,900,000 
 
 
Building and improvements
 
 
 
Property, Plant and Equipment
 
 
 
Gross property, plant, and equipment
51,979,000 
52,050,000 
 
Building and improvements |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
10 years 
 
 
Building and improvements |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
40 years 
 
 
Machinery and equipment
 
 
 
Property, Plant and Equipment
 
 
 
Gross property, plant, and equipment
104,815,000 
110,228,000 
 
Property, plant and equipment, net
 
 
 
Asset impairment charges
700,000 
 
 
Machinery and equipment |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
3 years 
 
 
Machinery and equipment |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
10 years 
 
 
Machinery and equipment |
Asia
 
 
 
Property, plant and equipment, net
 
 
 
Asset impairment
1,600,000 
 
 
Leaseholds improvements
 
 
 
Property, Plant and Equipment
 
 
 
Gross property, plant, and equipment
$ 4,356,000 
$ 5,888,000 
 
Leaseholds improvements |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
3 years 
 
 
Leaseholds improvements |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
7 years 
 
 
Accrued Expenses and Other Liabilities (Details) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Accrued Expenses and Other Current Liabilities
 
 
Payroll and related benefits
$ 26,605,000 
$ 11,020,000 
Sales, use and other taxes
1,776,000 
5,402,000 
Contingent consideration
 
20,098,000 
Warranty
5,411,000 
5,662,000 
Restructuring liability
1,428,000 
533,000 
Other
13,198,000 
8,369,000 
Total
48,418,000 
51,084,000 
Customer Deposits and Deferred Revenue
 
 
Customer deposits
$ 73,000,000 
$ 27,500,000 
Discontinued Operations (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Discontinued operations
 
Deferred pre-tax gain recognized on sale of business in China
$ 5,400,000 
Net income (loss) from discontinued operations
4,399,000 
Solar Systems
 
Discontinued operations
 
Net income (loss) from discontinued operations
(62,000)
Metrology
 
Discontinued operations
 
Deferred pre-tax gain recognized on sale of business in China
5,400,000 
Gain on sale of assets of discontinued segment
1,400,000 
Gain on sale of assets of discontinued segment, net of taxes
1,100,000 
Net income (loss) from discontinued operations
$ 4,461,000 
Restructuring Charges (Details) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Reconciliation of the restructuring liability
 
 
 
Balance at the beginning of the period
$ 533,000 
$ 1,875,000 
 
Provision
4,394,000 
1,485,000 
3,813,000 
Payments
(3,499,000)
(2,827,000)
 
Balance at the end of the period
1,428,000 
533,000 
1,875,000 
Personnel Severance and Related Costs
 
 
 
Reconciliation of the restructuring liability
 
 
 
Balance at the beginning of the period
533,000 
1,875,000 
 
Provision
4,012,000 
1,485,000 
 
Payments
(3,117,000)
(2,827,000)
 
Balance at the end of the period
1,428,000 
533,000 
1,875,000 
Personnel severance charges
 
 
3,800,000 
Number of employees impacted
93 
 
52 
Facility Closing Costs
 
 
 
Reconciliation of the restructuring liability
 
 
 
Provision
382,000 
 
 
Payments
(382,000)
 
 
Facility Closing Costs |
Ft. Collins, Colorado and Camarillo, California facilities
 
 
 
Reconciliation of the restructuring liability
 
 
 
Restructuring Costs
400,000 
 
 
Facility Closing Costs |
Forecast
 
 
 
Reconciliation of the restructuring liability
 
 
 
Provision
$ 500,000 
 
 
Commitments and Contingencies (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Accrued Warranty
 
 
Warranty period of products purchased
1 year 
 
Balance as of the beginning of the year
$ 5,662 
$ 4,942 
Addition for new warranties issued
3,484 
5,291 
Addition from PSP acquisition
809 
 
Settlements
(3,802)
(5,580)
Changes in estimate
(742)
1,009 
Balance as of the end of the year
$ 5,411 
$ 5,662 
Commitments and Contingencies (Details 2) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Minimum lease commitments for property and equipment
 
 
 
Rent expenses
$ 2,300,000 
$ 2,900,000 
$ 3,500,000 
Property and equipment
 
 
 
Minimum lease commitments for property and equipment
 
 
 
2015
2,322,000 
 
 
2016
2,423,000 
 
 
2017
1,993,000 
 
 
2018
1,224,000 
 
 
2019
526,000 
 
 
Thereafter
2,700,000 
 
 
Total
$ 11,188,000 
 
 
Commitments and Contingencies (Details 3)
12 Months Ended
Dec. 31, 2014
Accounts Receivable
Credit Concentration Risk
Top Ten Customers
item
Dec. 31, 2013
Accounts Receivable
Credit Concentration Risk
Top Ten Customers
Dec. 31, 2014
Accounts Receivable
Credit Concentration Risk
Customer B
Dec. 31, 2013
Accounts Receivable
Credit Concentration Risk
Customer B
Dec. 31, 2014
Accounts Receivable
Credit Concentration Risk
Customer C
Dec. 31, 2013
Accounts Receivable
Credit Concentration Risk
Customer C
Dec. 31, 2013
Accounts Receivable
Credit Concentration Risk
Customer D
Dec. 31, 2014
Net Sales
Customer Concentration Risk
Customer A
Dec. 31, 2014
Net Sales
Customer Concentration Risk
Customer B
Dec. 31, 2013
Net Sales
Customer Concentration Risk
Customer B
Dec. 31, 2012
Net Sales
Customer Concentration Risk
Customer D
Concentration of Credit Risk
 
 
 
 
 
 
 
 
 
 
 
Number of top customers
10 
 
 
 
 
 
 
 
 
 
 
Percentage of total accounts receivable from top customers
65.00% 
69.00% 
 
 
 
 
 
 
 
 
 
Concentration Risk (as a percent)
 
 
20.00% 
10.00% 
13.00% 
11.00% 
23.00% 
15.00% 
11.00% 
14.00% 
14.00% 
Commitments and Contingencies (Details 4) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2014
Minimum
Dec. 31, 2014
Maximum
Dec. 31, 2014
Asia Pacific
Dec. 31, 2013
Asia Pacific
Dec. 31, 2014
China
Dec. 31, 2013
China
Dec. 31, 2014
Korea
Dec. 31, 2013
Korea
Dec. 31, 2014
Thailand
Dec. 31, 2013
Thailand
Dec. 31, 2014
Taiwan
Dec. 31, 2013
Taiwan
Dec. 31, 2014
Other
Dec. 31, 2013
Other
Dec. 31, 2014
United States
Dec. 31, 2013
United States
Dec. 31, 2014
EMEA and other
Dec. 31, 2013
EMEA and other
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit period for accounts receivable
 
 
30 days 
90 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts Receivable, Net, Current
$ 60,085,000 
$ 23,823,000 
 
 
$ 42,177,000 
$ 13,899,000 
$ 17,911,000 
$ 4,130,000 
$ 8,118,000 
$ 2,411,000 
$ 6,324,000 
$ 2,041,000 
$ 5,838,000 
$ 427,000 
$ 3,986,000 
$ 4,890,000 
$ 13,139,000 
$ 8,369,000 
$ 4,769,000 
$ 1,555,000 
Purchase Commitments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchase commitments due within one year
112,400,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplier deposits against purchase commitments
$ 12,700,000 
$ 9,400,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commitments and Contingencies (Details 5) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Commitments and Contingencies
 
 
Bank guarantees outstanding
$ 45,000,000 
 
Restricted cash
539,000 
2,738,000 
Unused lines of credit
$ 26,000,000 
 
Debt (Details) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Long-term debt maturities
 
 
2015
$ 314,000 
 
2016
340,000 
 
2017
368,000 
 
2018
398,000 
 
2019
427,000 
 
Total long-term debt
1,847,000 
 
Less current portion
314,000 
290,000 
Total (less current maturities)
1,533,000 
1,847,000 
Mortgage Payable
 
 
Debt
 
 
Mortgage payable outstanding
1,800,000 
2,100,000 
Land and buildings
3,300,000 
4,700,000 
Number of buildings held for sale
 
Annual interest rate on mortgage (as a percent)
7.91% 
7.91% 
Mortgage Payable |
Level 3
 
 
Debt
 
 
Fair value of debt instrument
$ 2,000,000 
$ 2,300,000 
Derivative Financial Instruments (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Derivative financial instruments
 
 
 
Amount of realized net gain (loss) on derivatives
$ (546)
$ 1,154 
$ 333 
Foreign currency exchange forwards
 
 
 
Derivative financial instruments
 
 
 
Amount of realized net gain (loss) on derivatives
(89)
248 
333 
Foreign currency collar
 
 
 
Derivative financial instruments
 
 
 
Amount of realized net gain (loss) on derivatives
(457)
906 
 
Not Designated as Hedges
 
 
 
Derivative financial instruments
 
 
 
Fair value of derivative assets
 
907 
 
Notional amount of derivative instruments
 
38,769 
 
Not Designated as Hedges |
Foreign currency exchange forwards
 
 
 
Derivative financial instruments
 
 
 
Fair value of derivative assets
 
 
Notional amount of derivative instruments
 
4,700 
 
Not Designated as Hedges |
Foreign currency collar
 
 
 
Derivative financial instruments
 
 
 
Fair value of derivative assets
 
906 
 
Notional amount of derivative instruments
 
$ 34,069 
 
Stockholders' Equity (Details) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Aug. 24, 2010
Changes in the balances of each component of AOCI
 
 
 
 
Beginning Balance
$ 4,621,000 
$ 5,973,000 
 
 
Other comprehensive income (loss) before reclassifications
55,000 
(1,163,000)
 
 
Benefit (provision) for income taxes
 
(128,000)
 
 
Amounts reclassified from AOCI
(3,207,000)
(61,000)
 
 
Other comprehensive income (loss), net of tax
(3,152,000)
(1,352,000)
(617,000)
 
Ending Balance
1,469,000 
4,621,000 
5,973,000 
 
Authorized amount of common stock repurchase (in dollars)
 
 
 
200,000,000 
Treasury Stock
 
 
 
 
Changes in the balances of each component of AOCI
 
 
 
 
Treasury shares cancelled and retired
 
 
5,278,828 
 
Reduction due to retirement of treasury stock
 
 
(200,175,000)
 
Retained Earnings (Accumulated Deficit)
 
 
 
 
Changes in the balances of each component of AOCI
 
 
 
 
Reduction due to retirement of treasury stock
 
 
200,122,000 
 
Common Stock
 
 
 
 
Changes in the balances of each component of AOCI
 
 
 
 
Reduction due to retirement of treasury stock
 
 
53,000 
 
Foreign Currency Translation
 
 
 
 
Changes in the balances of each component of AOCI
 
 
 
 
Beginning Balance
5,326,000 
6,701,000 
 
 
Other comprehensive income (loss) before reclassifications
149,000 
(1,322,000)
 
 
Benefit (provision) for income taxes
 
(53,000)
 
 
Amounts reclassified from AOCI
(3,142,000)
 
 
 
Other comprehensive income (loss), net of tax
(2,993,000)
(1,375,000)
 
 
Ending Balance
2,333,000 
5,326,000 
 
 
Minimum pension liability
 
 
 
 
Changes in the balances of each component of AOCI
 
 
 
 
Beginning Balance
(736,000)
(775,000)
 
 
Other comprehensive income (loss) before reclassifications
(145,000)
125,000 
 
 
Benefit (provision) for income taxes
 
(86,000)
 
 
Other comprehensive income (loss), net of tax
(145,000)
39,000 
 
 
Ending Balance
(881,000)
(736,000)
 
 
Unrealized Gain on AFS Securities
 
 
 
 
Changes in the balances of each component of AOCI
 
 
 
 
Beginning Balance
31,000 
47,000 
 
 
Other comprehensive income (loss) before reclassifications
51,000 
34,000 
 
 
Benefit (provision) for income taxes
 
11,000 
 
 
Amounts reclassified from AOCI
(65,000)
(61,000)
 
 
Other comprehensive income (loss), net of tax
(14,000)
(16,000)
 
 
Ending Balance
$ 17,000 
$ 31,000 
 
 
Stock Plans (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Inducement Plan
Dec. 31, 2014
2010 Stock Incentive Plan
Dec. 31, 2014
2000 Stock Incentive Plan
Dec. 31, 2014
2000 Stock Incentive Plan
Minimum
Dec. 31, 2014
2000 Stock Incentive Plan
Maximum
Dec. 31, 2014
Stock Options
Dec. 31, 2013
Stock Options
Dec. 31, 2012
Stock Options
Dec. 31, 2011
Stock Options
Dec. 31, 2013
Stock Options
Inducement Plan
Dec. 31, 2014
Stock Options
Inducement Plan
Dec. 31, 2014
Stock Options
2010 Stock Incentive Plan
Dec. 31, 2014
Stock Options
2010 Stock Incentive Plan
Minimum
Dec. 31, 2014
Stock Options
2010 Stock Incentive Plan
Maximum
Dec. 31, 2014
Restricted Stock Awards and Restricted Stock Units
Dec. 31, 2013
Restricted Stock Awards and Restricted Stock Units
Dec. 31, 2012
Restricted Stock Awards and Restricted Stock Units
Dec. 31, 2014
Restricted Stock Awards and Restricted Stock Units
2010 Stock Incentive Plan
Minimum
Dec. 31, 2014
Restricted Stock Awards and Restricted Stock Units
2010 Stock Incentive Plan
Maximum
Dec. 31, 2014
Restricted Stock Units
Dec. 31, 2014
Restricted Stock Units
Minimum
Dec. 31, 2014
Restricted Stock Units
Maximum
Dec. 31, 2013
Restricted Stock Units
Inducement Plan
Dec. 31, 2014
Restricted Stock Units
Inducement Plan
Dec. 31, 2013
Restricted Stock Units
Inducement Plan
Minimum
Dec. 31, 2013
Restricted Stock Units
Inducement Plan
Maximum
Dec. 31, 2014
Restricted Stock Units
2010 Stock Incentive Plan
Dec. 31, 2014
Restricted Stock Awards
Dec. 31, 2014
Restricted Stock Awards
Minimum
Dec. 31, 2014
Restricted Stock Awards
Maximum
Dec. 31, 2014
Performance Share Units
Dec. 31, 2014
Performance Share Awards
Equity Compensation Plans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock issued (in shares)
 
 
 
 
 
 
 
 
 
 
124,500 
 
 
 
 
 
 
 
 
 
 
 
 
87,000 
 
 
 
 
 
 
 
 
 
Maximum number of shares authorized to be issued
 
 
6,800,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock available for issuance (in shares)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vesting period
 
 
 
 
2 years 
5 years 
 
 
 
 
3 years 
 
3 years 
 
 
 
 
 
1 year 
5 years 
 
1 year 
5 years 
 
 
2 years 
4 years 
 
 
 
 
 
 
Term of awards
 
 
 
 
 
 
 
 
 
 
10 years 
 
 
7 years 
10 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of options outstanding (in shares)
 
 
 
400,000 
 
 
2,391,000 
2,598,000 
2,322,000 
2,106,000 
 
124,500 
1,900,000 
 
 
 
 
 
 
 
 
 
 
 
82,700 
 
 
400,000 
 
 
 
 
 
Awards granted (in shares)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
395,000 
798,000 
324,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expiration term
 
 
 
7 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 year 
5 years 
 
 
Unrecognized share-based compensation costs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unrecognized Share-Based Compensation Costs
$ 40,427 
 
 
 
 
 
$ 9,939 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 9,980 
 
 
 
 
 
 
 
$ 17,501 
 
 
$ 2,855 
$ 152 
Weighted Average Period Expected to be Recognized
2 years 6 months 
 
 
 
 
 
2 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 years 6 months 
 
 
 
 
 
 
 
2 years 9 months 18 days 
 
 
3 years 3 months 18 days 
4 months 24 days 
Vested
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
 
 
 
 
 
1,409,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Exercise Price
 
 
 
 
 
 
$ 30.76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Remaining Contractual Life
 
 
 
 
 
 
5 years 2 months 12 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aggregate Intrinsic Value
 
 
 
 
 
 
10,127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected to vest
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of shares
 
 
 
 
 
 
903,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Exercise Price
 
 
 
 
 
 
$ 32.93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Remaining Contractual Life
 
 
 
 
 
 
7 years 8 months 12 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aggregate Intrinsic Value
 
 
 
 
 
 
2,091 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of shares
 
 
 
 
 
 
2,312,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Exercise Price
 
 
 
 
 
 
$ 31.61 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Remaining Contractual Life
 
 
 
 
 
 
6 years 2 months 12 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aggregate Intrinsic Value
 
 
 
 
 
 
$ 12,218 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Closing price
 
 
 
 
 
 
$ 34.88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock, Capital Shares Reserved for Future Issuance upon Exercise of Stock Options and Grants of Restricted Stock
 
 
4,900,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock Plans (Details 2) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Options Exercisable
 
 
 
Shares
1,409,000 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 30.76 
 
 
Recognized share-based compensation
 
 
 
Share-based compensation expense before tax
$ 18,813 
$ 13,132 
$ 13,853 
Income tax benefit
(6,011)
(4,367)
(4,849)
Net share-based compensation expense
12,802 
8,765 
9,004 
Cost of Sales
 
 
 
Recognized share-based compensation
 
 
 
Share-based compensation expense before tax
2,456 
1,446 
1,467 
Selling, General and Administrative Expenses
 
 
 
Recognized share-based compensation
 
 
 
Share-based compensation expense before tax
11,859 
8,339 
9,677 
Research and Development Expense
 
 
 
Recognized share-based compensation
 
 
 
Share-based compensation expense before tax
$ 4,498 
$ 3,347 
$ 2,709 
Stock Options
 
 
 
Stock option awards, Shares
 
 
 
Outstanding at the beginning of the period (in shares)
2,598,000 
2,322,000 
2,106,000 
Granted (in shares)
509,000 
539,000 
704,000 
Exercised (in shares)
(561,000)
(149,000)
(351,000)
Expired or forfeited (in shares)
(155,000)
(114,000)
(137,000)
Outstanding at the end of the period (in shares)
2,391,000 
2,598,000 
2,322,000 
Weighted Average Exercise price
 
 
 
Outstanding at the beginning of the period (in dollars per share)
$ 29.98 
$ 28.63 
$ 25.58 
Granted (in dollars per share)
$ 33.05 
$ 32.68 
$ 32.55 
Exercised (in dollars per share)
$ 23.88 
$ 14.74 
$ 15.39 
Expired or terminated (in dollars per share)
$ 36.22 
$ 35.22 
$ 35.88 
Outstanding at the end of the period (in dollars per share)
$ 31.65 
$ 29.98 
$ 28.63 
Stock Plans (Details 3) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Options Outstanding
 
 
 
Shares
2,391 
 
 
Aggregate Intrinsic Value
$ 12,395 
 
 
Weighted-Average Remaining Contractual Life
6 years 2 months 12 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 31.65 
 
 
Options Exercisable
 
 
 
Shares
1,409 
 
 
Aggregate Intrinsic Value
10,127 
 
 
Weighted Average Remaining Contractual life
5 years 2 months 12 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 30.76 
 
 
Assumptions based on which fair value of each option granted was estimated using the Black-Scholes option-pricing model
 
 
 
Cash received from options exercised
12,056 
2,199 
5,409 
Intrinsic value of options exercised
8,390 
2,509 
6,800 
$8.82 - $17.48
 
 
 
Information about stock options outstanding
 
 
 
Exercise price, low end of range (in dollars per share)
$ 8.82 
 
 
Exercise price, high end of range (in dollars per share)
$ 17.48 
 
 
Options Outstanding
 
 
 
Shares
386 
 
 
Aggregate Intrinsic Value
8,769 
 
 
Weighted-Average Remaining Contractual Life
1 year 3 months 18 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 12.15 
 
 
Options Exercisable
 
 
 
Shares
386 
 
 
Aggregate Intrinsic Value
8,769 
 
 
Weighted Average Remaining Contractual life
1 year 3 months 18 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 12.15 
 
 
$20.80 - $31.45
 
 
 
Information about stock options outstanding
 
 
 
Exercise price, low end of range (in dollars per share)
$ 20.80 
 
 
Exercise price, high end of range (in dollars per share)
$ 31.45 
 
 
Options Outstanding
 
 
 
Shares
347 
 
 
Aggregate Intrinsic Value
1,626 
 
 
Weighted-Average Remaining Contractual Life
8 years 9 months 18 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 30.20 
 
 
Options Exercisable
 
 
 
Shares
125 
 
 
Aggregate Intrinsic Value
616 
 
 
Weighted Average Remaining Contractual life
8 years 8 months 12 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 29.94 
 
 
$31.91 - $48.04
 
 
 
Information about stock options outstanding
 
 
 
Exercise price, low end of range (in dollars per share)
$ 31.91 
 
 
Exercise price, high end of range (in dollars per share)
$ 48.04 
 
 
Options Outstanding
 
 
 
Shares
1,429 
 
 
Aggregate Intrinsic Value
2,000 
 
 
Weighted-Average Remaining Contractual Life
6 years 10 months 24 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 34.14 
 
 
Options Exercisable
 
 
 
Shares
669 
 
 
Aggregate Intrinsic Value
$ 742 
 
 
Weighted Average Remaining Contractual life
6 years 4 months 24 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 34.63 
 
 
$48.90 - $51.70
 
 
 
Information about stock options outstanding
 
 
 
Exercise price, low end of range (in dollars per share)
$ 48.90 
 
 
Exercise price, high end of range (in dollars per share)
$ 51.70 
 
 
Options Outstanding
 
 
 
Shares
229 
 
 
Weighted-Average Remaining Contractual Life
6 years 4 months 24 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 51.21 
 
 
Options Exercisable
 
 
 
Shares
229 
 
 
Weighted Average Remaining Contractual life
6 years 4 months 24 days 
 
 
Weighted-Average Exercise Price (in dollars per share)
$ 51.21 
 
 
Stock Options
 
 
 
Assumptions based on which fair value of each option granted was estimated using the Black-Scholes option-pricing model
 
 
 
Weighted average fair value
$ 11.58 
$ 13.47 
$ 15.56 
Dividend yield
0.00% 
0.00% 
0.00% 
Expected volatility factor
44.00% 
49.00% 
59.00% 
Risk-free interest rate
1.19% 
1.27% 
0.70% 
Expected life (in years)
3 years 10 months 24 days 
4 years 6 months 
4 years 6 months 
Stock Plans (Details 4) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Weighted-Average Grant-Date Fair Value
 
 
 
Dividends expected to be paid
$ 0 
 
 
Total grant date fair value of shares vested
$ 6,200,000 
$ 7,900,000 
$ 5,400,000 
Restricted Stock Awards and Restricted Stock Units
 
 
 
Restricted stock awards including restricted stock units, Shares
 
 
 
Outstanding at the beginning of the period (in shares)
1,158 
693 
618 
Granted (in shares)
395 
798 
324 
Released (in shares)
(183)
(207)
(167)
Forfeitures (in shares)
(133)
(126)
(82)
Outstanding at the end of the period (in shares)
1,237 
1,158 
693 
Weighted-Average Grant-Date Fair Value
 
 
 
Outstanding at the beginning of the period (in dollars per share)
$ 34.93 
$ 36.11 
$ 33.61 
Granted (in dollars per share)
$ 34.18 
$ 33.16 
$ 32.62 
Released (in dollars per share)
$ 38.65 
$ 32.44 
$ 20.60 
Forfeitures (including cancelled awards) (in dollars per share)
$ 33.66 
$ 34.33 
$ 34.98 
Outstanding at the end of the period (in dollars per share)
$ 34.27 
$ 34.93 
$ 36.11 
Restricted Stock Awards |
Minimum
 
 
 
Weighted-Average Grant-Date Fair Value
 
 
 
Expiration term
1 year 
 
 
Restricted Stock Awards |
Maximum
 
 
 
Weighted-Average Grant-Date Fair Value
 
 
 
Expiration term
5 years 
 
 
Restricted Stock Units |
Minimum
 
 
 
Weighted-Average Grant-Date Fair Value
 
 
 
Vesting period
1 year 
 
 
Restricted Stock Units |
Maximum
 
 
 
Weighted-Average Grant-Date Fair Value
 
 
 
Vesting period
5 years 
 
 
Retirement Plans (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
item
Dec. 31, 2013
Dec. 31, 2012
Sep. 30, 2014
item
Employer's matching contribution for every dollar the employees contribute (as a percent)
50.00% 
 
 
 
Employer's matching contribution, vesting period (in years)
5 years 
 
 
 
Number of foreign subsidiaries with defined contribution plan
 
 
 
Aggregate employer's contribution to pension plans
$ 1.9 
$ 2.3 
$ 2.5 
 
Number of participants
 
 
 
73 
Contract assets under the plan
 
 
 
$ 1.5 
Maximum
 
 
 
 
Employer's contribution as a percentage of employee's eligible compensation
3.00% 
 
 
 
Employer's contribution as a percentage of the maximum an employee is permitted to contribute under IRS limits
3.00% 
 
 
 
Income Taxes (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Income (loss) from continuing operations before income taxes
 
 
 
Domestic
$ (95,195)
$ (84,942)
$ 5,811 
Foreign
16,841 
13,732 
32,375 
Income (loss) from continuing operations before income taxes
$ (78,354)
$ (71,210)
$ 38,186 
Income Taxes (Details 2) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Current:
 
 
 
Federal
$ (2,464)
$ (21,022)
$ 2,515 
Foreign
2,325 
3,921 
7,576 
State and local
55 
148 
(317)
Total current provision (benefit) for income taxes
(84)
(16,953)
9,774 
Deferred:
 
 
 
Federal
(11,230)
(11,589)
(482)
Foreign
(291)
(462)
727 
State and local
191 
57 
1,638 
Total deferred provision (benefit) for income taxes
(11,330)
(11,994)
1,883 
Total provision (benefit) for income taxes
$ (11,414)
$ (28,947)
$ 11,657 
Income Taxes (Details 3) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 4, 2014
PSP
Income Taxes
 
 
 
 
 
Income tax provision (benefit) at U.S. statutory rates
 
$ (27,424,000)
$ (24,923,000)
$ 13,366,000 
 
State taxes, net of U.S. federal impact
 
(662,000)
(1,554,000)
(89,000)
 
Effect of international operations
 
(6,160,000)
(4,275,000)
(2,387,000)
 
Domestic production activities deduction
 
 
1,554,000 
(489,000)
 
Research and development tax credit
 
(1,935,000)
(3,151,000)
(3,013,000)
 
Net change in valuation allowance
 
27,156,000 
2,420,000 
2,943,000 
 
Change in accrual for unrecognized tax benefits
 
(1,940,000)
577,000 
533,000 
 
Goodwill impairment
 
9,786,000 
 
 
 
Change in contingent consideration
 
(10,279,000)
290,000 
 
 
Other
 
44,000 
115,000 
793,000 
 
Total provision (benefit) for income taxes
 
(11,414,000)
(28,947,000)
11,657,000 
 
Reversal of additional tax of foreign jurisdiction
4,900,000 
 
 
 
 
Excess tax benefits from stock option exercises not recorded
 
600,000 
500,000 
 
 
Excess tax benefits from stock option exercises
 
 
 
2,100,000 
 
Income taxes
 
 
 
 
 
Deferred tax liability related to acquisition
 
 
 
 
$ 2,700,000 
Income Taxes (Details 4) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Deferred tax assets:
 
 
Inventory valuation
$ 8,244,000 
$ 6,983,000 
Net operating losses and credit carry forwards
39,750,000 
18,972,000 
Warranty and installation accruals
2,452,000 
3,002,000 
Share-based compensation
11,794,000 
10,638,000 
Other
2,647,000 
3,716,000 
Total deferred tax assets
64,887,000 
43,311,000 
Valuation allowance
(34,909,000)
(7,753,000)
Net deferred tax assets
29,978,000 
35,558,000 
Deferred tax liabilities:
 
 
Purchased intangible assets
34,018,000 
45,208,000 
Undistributed earnings
1,047,000 
1,737,000 
Depreciation
2,274,000 
4,711,000 
Total deferred tax liabilities
37,339,000 
51,656,000 
Net deferred taxes
(7,361,000)
(16,098,000)
Undistributed earnings of foreign subsidiaries
115,800,000 
101,000,000 
Valuation allowance
 
 
Increase in valuation allowance
27,200,000 
 
Federal
 
 
Valuation allowance
 
 
Net operating loss carryforwards
53,300,000 
 
Research and development tax credits
9,200,000 
 
Foreign
 
 
Valuation allowance
 
 
Net tax credit carryforwards
$ 7,000,000 
 
Income Taxes (Details 5) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Change in unrecognized tax benefits
 
 
 
Balance at the beginning of the year
$ 6,228,000 
$ 5,818,000 
$ 4,748,000 
Additions for tax positions related to current year
244,000 
324,000 
435,000 
Additions for tax positions relating to prior years
199,000 
477,000 
742,000 
Reductions for tax positions relating to prior years
(2,345,000)
(224,000)
(59,000)
Reductions due to the lapse of the applicable statute of limitations
(38,000)
 
(48,000)
Settlements
(12,000)
(167,000)
 
Balance at the end of the year
4,276,000 
6,228,000 
5,818,000 
Amount of unrecognized tax benefits that would affect effective tax rate
4,300,000 
6,200,000 
 
Accrued interest and penalties related to unrecognized tax benefits
300,000 
800,000 
 
2010 IRS settlement
 
 
 
Change in unrecognized tax benefits
 
 
 
Settlements
$ 2,300,000 
 
 
Segment Reporting and Geographic Information (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
$ 113,569 
$ 93,341 
$ 95,122 
$ 90,841 
$ 73,209 
$ 99,324 
$ 97,435 
$ 61,781 
$ 392,873 
$ 331,749 
$ 516,020 
Long-Lived Assets
78,752 
 
 
 
89,139 
 
 
 
78,752 
89,139 
98,302 
United States
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
44,060 
57,609 
83,317 
Long-Lived Assets
63,349 
 
 
 
66,002 
 
 
 
63,349 
66,002 
74,497 
Asia Pacific
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
311,182 
252,199 
390,995 
Long-Lived Assets
15,325 
 
 
 
23,042 
 
 
 
15,325 
23,042 
23,769 
China |
Net Sales to Customers |
Geographic Concentration Risk
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Percentage of net sales of customers to total net sales
 
 
 
 
 
 
 
 
40.00% 
45.00% 
42.00% 
EMEA and other
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
37,631 
21,941 
41,708 
Long-Lived Assets
78 
 
 
 
95 
 
 
 
78 
95 
36 
MOCVD
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
279,751 
219,914 
314,152 
MBE
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
28,033 
29,419 
49,029 
Surface Processing
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
7,906 
 
 
Ion Beam and other
 
 
 
 
 
 
 
 
 
 
 
Net sales attributable to the geographic location in which the customer facility is located and long-lived assets related to operations in United States and other foreign countries
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
$ 77,183 
$ 82,416 
$ 152,839 
Selected Quarterly Financial Information (unaudited) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Quarterly Financial Information
 
 
 
 
 
 
 
 
 
 
 
Net sales
$ 113,569 
$ 93,341 
$ 95,122 
$ 90,841 
$ 73,209 
$ 99,324 
$ 97,435 
$ 61,781 
$ 392,873 
$ 331,749 
$ 516,020 
Gross Profit
37,874 
32,558 
30,673 
33,777 
15,642 
30,308 
34,640 
22,552 
134,882 
103,142 
215,133 
Net income (loss)
$ (56,912)
$ (13,977)
$ (15,211)
$ 19,160 
$ (22,085)
$ (6,026)
$ (4,081)
$ (10,071)
$ (66,940)
$ (42,263)
$ 30,928 
Basic income (loss) per common share
$ (1.44)
$ (0.35)
$ (0.39)
$ 0.49 
$ (0.57)
$ (0.16)
$ (0.11)
$ (0.26)
$ (1.70)
$ (1.09)
$ 0.80 
Diluted income (loss) per common share
$ (1.44)
$ (0.35)
$ (0.39)
$ 0.48 
$ (0.57)
$ (0.16)
$ (0.11)
$ (0.26)
$ (1.70)
$ (1.09)
$ 0.79 
Selected Quarterly Financial Information (unaudited) (Details 2) (USD $)
12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2014
ALD
Mar. 31, 2014
ALD
Dec. 31, 2014
ALD
Dec. 31, 2013
ALD
Synos Acquisition
 
 
 
 
 
 
 
Asset impairment
$ 58,170,000 
$ 1,220,000 
$ 1,335,000 
$ 53,900,000 
 
 
 
Change in contingent consideration
 
 
 
 
$ 29,400,000 
$ 29,400,000 
$ (800,000)
Schedule II-Valuation and Qualifying Accounts (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Valuation and Qualifying Accounts
 
 
 
Balance at Beginning of Period
$ 10,191 
$ 5,200 
$ 2,233 
Charged (Credited) to Costs and Expenses
25,342 
4,366 
3,141 
Charged to Other Accounts
325 
625 
 
Deductions
(218)
 
(174)
Balance at End of Period
35,640 
10,191 
5,200 
Allowance for doubtful accounts
 
 
 
Valuation and Qualifying Accounts
 
 
 
Balance at Beginning of Period
2,438 
492 
468 
Charged (Credited) to Costs and Expenses
(1,814)
1,946 
198 
Charged to Other Accounts
325 
 
 
Deductions
(218)
 
(174)
Balance at End of Period
731 
2,438 
492 
Valuation allowance in net deferred tax assets
 
 
 
Valuation and Qualifying Accounts
 
 
 
Balance at Beginning of Period
7,753 
4,708 
1,765 
Charged (Credited) to Costs and Expenses
27,156 
2,420 
2,943 
Charged to Other Accounts
 
625 
 
Balance at End of Period
$ 34,909 
$ 7,753 
$ 4,708